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ABSTRACT OF THE DISSERTATION
TOWARD STABLE ELECTROCHEMICAL SENSING FOR WEARABLE WOUND
MONITORING
by
Sohini RoyChoudhury
Florida International University, 2019
Miami, Florida
Professor Shekhar Bhansali, Major Professor
Wearable biosensing has the tremendous advantage of providing point-of-care
diagnosis and convenient therapy. In this research, methods to stabilize the electrochemical
sensing response from detection of target biomolecules, Uric Acid (UA) and Xanthine,
closely linked to wound healing, have been investigated. Different kinds of materials have
been explored to address such detection from a wearable, healing platform.
Electrochemical sensing modalities have been implemented in the detection of purine
metabolites, UA and Xanthine, in the physiologically relevant ranges of the respective
biomarkers. A correlation can be drawn between the concentrations of these bio-analytes
and wound severity, thus offering probable quantitative insights on wound healing
progression. These insights attempt to contribute in reducing some impacts of the financial
structure on the healthcare economy associated with wound-care.
An enzymatic electrochemical sensing system was designed to provide quick
response at a cost-effective, miniaturized scale. Robust enzyme immobilization protocols
have assisted in preserving enzyme activity to offer stable response under relevant
variations of temperature and pH, from normal. Increased hydrophilicity of the sensor
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surface using corona plasma, has assisted in improving conductivity, thus allowing for
increased electroactive functionalization and loading across the substrate’s surface.
Superior sensor response was attained from higher loading of nanomaterials
(MWCNT/AuNP) and enzymes (UOx/XO) employed in detection.
Potentiometric analyses of the nanomaterial modified enzymatic biosensors were
conducted using cyclic voltammetry (CV) and differential pulse voltammetry (DPV)
modalities. Under relevant physiological conditions, the biosensor was noted to offer a
variation in response between 10 % and 30 % within a week. Stable, reproducible results
were obtained from repeated use of the biosensor over multiple days, also offering promise
for continuous monitoring. Shelf life of the biosensor was noted to be more than two days
with response retained by about 80 % thereafter. Secondary analyses have been performed
utilizing the enzymatic biosensor to explore the feasibility of target biomarker detection
from clinical extracts of different biofluids for wound monitoring. Biosensor response
evaluation from the extracts of human wound exudate, and those obtained from perilesional
and healthy skin, provided an average recovery between 107 % and 110 % with a deviation
within (+/-) 6 %. Gradual decrease in response (10-20 %) was noted in detection from
extracts further away from injury site. Increased accumulation of biofluids on the sensor
surface was studied to explore sensor response stability as a function of sample volume.
With a broad linear range of detection (0.1 nM – 7.3 mM) and detection limits lower than
the physiological concentrations, this study has assessed the viability of stable wound
monitoring under physiologically relevant conditions on a wearable platform.
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CHAPTER 1
INTRODUCTION
1.1 Motivation
A growing need exists for personalized medicine in global healthcare. Smart
healthcare technologies draw the attention of scientists and researchers to bring
breakthroughs in medical science. Accordingly, there is a demand for robust, flexible
biosensing platforms in clinical applications for disease diagnosis and treatment
monitoring.[1] Provision of point-of-care (POC) medical facilities can offer the
tracking of vital health parameters and, in turn, reduce the outcomes of delayed
treatment and associated costs. Wearable biosensing has of late garnered considerable
interest in personal diagnostics and health management. There is renewed interest in
flexible platform technologies due to their low cost, light weight, low modulus and high
stretchability.[2] Such intrinsic factors are paramount to the convenient provision of
health parameters on a flexible, biocompatible platform that can facilitate timely
decisions for effective therapy. These platform technologies aim to provide alternative
solutions to POC diagnostic assays for broad applications in personalized medicine and
offer valuable insights into one’s physiological conditions, from continuous monitoring
of an individual’s biomarkers in real-time.
Commercially available biosensors are based on conventional electronic technology
that is yet to adhere perfectly to wearable-form factors and conditions. Quantum
advancements are being made to engineer soft, flexible biosensors with tunable
electrochemical and electromechanical properties. These are expected to provide
accurate and reliable sensing without compromising on the natural movement and
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comfort of its users.[3] Although wearable biosensing gains significant attention in
personal health management, there are constraints interfering with reliable and
convenient operation from a wearable construct. Such constraints can be attributed to
differences in electrode-skin interface impedance and contact surface area, that affect
the reproducibility and stability of performance. The incompatibility between existing
techniques and flexible substrates, demands a revolution in material science and the
fabrication processes involved.[4]
Detection of physiological biochemical indicators can utilize the natural human
metabolic pathways to assess wellness parameters. This process entailing the use of
enzymes provides for a natural, biocompatible approach in biosensing. Inclusion of
enzymes in detection is influenced by the catalytic properties of the enzyme activity
and its stability over time. Enzymes, which act as catalysts in a bio-chemical reaction,
are reportedly active at specific pH and temperature, and are known to fade over
variations. [5] As a result, stability of enzymatic response at higher temperatures and
different pH can vary over time.
Pertinent factors that affect the electrochemical response of a system arise from
variations in electrode distances and area, which can consequentially alter performance.
This work focuses on addressing some challenges faced in electrochemical detection
of specific biomolecules from a wearable construct. Possible variations in response
stability have been addressed through precise selection of substrate materials and robust
enzyme immobilization protocols. Surface modification methods have been utilized to
improve substrate hydrophilicity and enable higher enzyme loading for improved
response and minimal variation in stability. Nano-material scaffolds have been
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employed for improved surface interactions and accelerated electron transfer. The
integration of specific nano-composite material enables enhanced response with
minimal variation.
Electrochemical analyses have been conducted using enzymatic sensors designed
on different substrate materials, to assess any degrade in sensor stability and
reproducibility under physiologically relevant variations. Enzymatic sensors can be
designed at a cost-effective, miniaturized scale through micro/nano fabrication
processes. The use of enzymes enable quick detection with low response time and can
potentially offer the tremendous advantage of convenient, personalized therapy. [6]
Conventional wound-care protocols are primarily visual or entail colorimetric and
optical detection approaches to assess lesion width and depth. These systems are bulky,
expensive, and do not provide rapid results for a comprehensive understanding of tissue
recovery. In this study, purine metabolites such as uric acid (UA) and Xanthine, which
can report changes in tissue recovery from longitudinal measurements, have been
investigated as target biomarkers for wound monitoring, through enzymatic detection.
Sensor material and design configurations have been carefully tailored, and specific
techniques have been employed to achieve minimal variation in response within the
concerned physiological ranges. The need for this study has thus been, to design
electrochemical sensors on a wearable construct, and to identify and engineer stable
pathways for enzymatic detection of the concerned biomarkers in wound monitoring.
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1.2 Specific Aims and Objectives
The specific objectives in this study have been as follows:
i. Examine the effects of enzymatic performance for minimal variation under relevant
conditions of temperature and pH
Hypothesis – Enzymes fade over variations of pH and temperature, that affects sensor
response.
ii. Investigate a nanocomposite of MWCNT/AuNP for enhanced sensing response
Hypothesis – Composite of MWCNT/AuNP nano-scaffolds increase electroactive area,
surface conductivity and binding sites, thereby increasing sensor signal, as compared
to their isolated presence or absence on bare or enzymatic electrodes.
iii. Understand the effects of sensor material properties on substrate functionalization for
improved performance
Hypothesis – Increased hydrophobicity of sensor surface reduces loading and
functionalization across the substrate surface, thereby attenuating sensor response.
iv. Validate sensor performance through secondary analysis of extracted clinical samples
of biological fluids against standard colorimetric assay.
A nano-composite functionalized enzymatic sensor was designed in this study for the
investigation of target biomolecules in extracts of wound exudate and sweat from around
perilesional and healthy skin. Correlations obtained provide for a non-invasive method to
quantify wound severity and healing progress from around wound milieu.
1.3 Dissertation Organization
In Chapter 2, a comprehensive discussion on existing state-of-the-art wearable
biosensing and wound care detection is presented, with a review of the advantages and
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limitations of conventional techniques. The physiology and relevance of wound care
biomarkers, namely UA and Xanthine, are discussed herein, elucidating their biochemical
correlation with wound monitoring. Besides these bio-physiological indicators, certain
environmental indicators (pH, temperature) are also discussed. An overview of the
different kinds of materials and techniques being explored in such detection have been
reported.
Chapter 3 presents the details of experimental procedures employed in enzymatic
detection of UA. Suitable substrate functionalization and enzyme immobilization
techniques that were adopted in investigating UA detection, have been stated.
Characterization methods to explore the stability of enzymatic detection have been
elaborated in this chapter. The feasibility of detection under physiologically relevant
environmental variations is reported herein.
Chapter 4 presents the details of experimental protocols utilized in Xanthine detection.
Synthesis of a hybrid nanocomposite matrix which assisted in maintaining enzyme stability
to obtain enhanced signal, has been described here. Imaging analyses of the nanomaterial
modified sensor surface have offered information on surface morphology, roughness and
conductivity. Analysis of the electrochemical response obtained from the nanomaterial
functionalized electroactive substrates have been evaluated in this chapter.
Chapter 5 presents the effects of sensor material properties on performance. Specific
techniques utilized to improve hydrophilicity of the sensor surface to achieve increased
functionalization and loading for higher signal, have been reported here. Secondary
analyses from clinical extracts of physiologically relevant biological fluids have been
investigated to validate sensor response. Feasibility for potential non-invasive detection of
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target bio-analytes has been considered here. The viability of sensor design and detection
from a flexible, healing platform has been assessed in this chapter for wearable wound
monitoring.
Chapter 6 summarizes the design, fabrication, and characterization of electrochemical
sensors for wearable wound monitoring applications. Concluding remarks and prospects
of the research work undertaken have been directed in this chapter.
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CHAPTER 2
LITERATURE REVIEW
2.1 Wearable biosensing
A wearable biosensor is a digital device that can be worn on the body in combination
with a self-contained integrated device capable of providing specific quantitative analytical
information. It does so by using a biological recognition element which is in direct spatial
contact with a physiochemical transducer. An electrochemical wearable biosensor is a
body-borne system that is intended to continuously interact with the wearer and produce
an electronic signal proportional to a single bio-analyte.[7] The acquired bio-physiological
information can then be conveyed to an associated electronic device and sent wirelessly to
healthcare providers. This two-way feedback between a patient and doctor made possible
at the remote level can offer substantial potential in medical IoT (internet of things),
allowing to bring medical assistance to a personalized scale.[8]
Wearable biosensors can be made operational based on three important criteria:
wearability, reliability and convenience. Without wearability, utility of the device will be
limited to users who demand valid data for informed clinical decisions. For the system to
be wearable, the users’ convenience and comfort are of upmost importance, without which
user engagement will not be achieved.[9]
2.1.1

Current state-of-the-art in wearable biosensing

Device geometries for precise body to signal transduction include systems with largescale set-ups designed for laboratory settings. This includes primitive functional platforms
that integrate consumer electronic goods, such as wrist-mounted wearables, to newly
emerging skin-like devices that combine the attractive features of the two.
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A lot of research has been continuing in body-sensor-networks to integrate biosensors
into wearable platforms like watch, bracelet, belt, patch, eyewear and textile; made
functional with the use of smart technology. Such systems are of late gaining immense
interest for providing continuous measurements of various biometric data. Currently, stateof-the-art devices in wearable biosensing typically include measurements of different
physiological parameters like heart rate, blood pressure, wake-sleep patterns, respiration
rate, oxygen levels, blood glucose levels and physical activity in real time. [10,11]
In comparison, relatively little has been accomplished in wearable biochemical
sensors, which can be useful for personal management of wellness, through non-invasive
monitoring of target biomarkers. This is possible through the detection of relevant
biomolecules from different biological fluids such as sweat, saliva, tear and urine of the
user. The accomplishment of such sensors has been a mixture of both progress and
setbacks.[12] Most commercial advancement is being made with the smart adaptation of
existing mechanical, electrical and optical techniques of measuring concerned parameters.
This involves innovation in miniaturization of sensing technologies to make them
conformal to the skin surface.[12] Challenges associated with specific detection of
concerned analytes, attribute to interference from other predominant analytes in the
sampling matrix, and the impedance associated with diffusion of ions through different
layers of the skin. [13-14]
2.1.2

Detection mechanisms explored in wearable biosensing

Capacitive pressure sensors are being employed in human pressure sensing interfaces
to mimic tactile sensation and joint bending detection. For example, the flexible parallel
plate capacitive system by Pressure Profile Systems, Inc. (PPS) (Figure 2.1a) has the ability

8

of flexible tactile sensation and body pressure mapping.[15] By results of ease of
improvements in design flexibility and stretchability, new electrode materials for
capacitive sensors thus draw awareness.[16] To best match skin modulus, silicone
elastomers like polydimethylsiloxane (PDMS) are being used to design such skin
conformal biosensing systems. Detection of human radial artery pulse waves is being
explored using capacitive pressure and strain sensing using micro-patterned conductive
polymer films. Piezo-resistive effect of strain sensors are known to be used in wearable
electronics to detect human physiological movement.[17] For reconstructing wrist and
finger tactile sensations, ionic liquids are being employed as sensing elements to resolve
contact forces in flexible and transparent microfluidic systems.[18]

(b)

(a)

(c)

(d)

Figure 2.1. (a) TactArray, flexible capacitive array tactile sensor from Pressure
Profile Systems[15], (b) Flexible, wearable disposable cardiac biosensor for remote
and ambulatory monitoring[19]; (c) Wearable sensor array for multiplexed in situ
perspiration analysis[21]; (d) Tattoo biosensor for monitoring electrolytes from
sweat[26]
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Electrophysiological sensing techniques provide measurements of ECG, EKG, EMG,
EOG, and EEG. Besides tracking body motion and temperature using thermal sensing,
optical detection is employed by compact wearable diagnostic devices to capture heart rate
and oxygenation (Figure 2.1b).[19] In order to acquire the required biological information,
the processes of light scattering and absorption on skin are employed.

Although

qualitative, chemical-to-optical transduction, enable cost-effective detection with system
design simplicity. Such methodologies establish clinical relevance in the assessment of
cardiovascular, myocardial and tissue health.[12]
Electrochemical sensing for continuous monitoring of chemical biomarkers at the
molecular level in real-time is yet to be achieved in wearable biosensing. Such sensing
systems operate through chemical-to-electrical signal conduction, generating an electrical
signal from a chemical reaction between ions in a sampling biomatrix and a transducer.[20]
This can be attained from direct access to analytes in bio-fluid matrices secreted from the
body.
These systems can meet the criteria for wearable biosensing owing to their inherent
miniaturization ability, low power requirements, simplicity, speed and low-cost
fabrication. Recent efforts have demonstrated the design of epidermal electrochemical
sensors that can endure mechanical strains and stretching on skin conformal surface with
minimal compromise on performance. Multi-analyte electrochemical sensing platforms are
being designed on wristband based wearable constructs, to monitor the wearer's body
temperature and levels of glucose, lactate, potassium, sodium from human sweat. Body
compliant spatio-temporal mapping of localized ion concentration has been achieved to
monitor transient electrolyte concentration profiles and then alert the wearer of potential
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health risks. This multi-sensor epidermal platform (Figure 2.1c) merges plastic-based
sensor arrays with silicon integrated circuits consolidated on a flexible circuit board for
advanced signal conditioning, processing and transmission.[21] Such sensors utilize
enzymes pertaining to human bio-chemical pathways as natural catalysts to enhance
sensing performance. This shows the biocompatibility of enzymes, with excellent
specificity to the concerned biochemical pathway.
Among different sampling biomatrices being explored for minimally invasive detection
of bioanalytes; sweat, saliva and tear are known for the presence of multiple
physiologically relevant chemical constituents. Flexible tattoo and textile based
amperometric and potentiometric sensors as seen in Figure 2.1d demonstrate the detection
of certain analytes like glucose[22-25] and lactate[26-29] from human sweat, along with
determining the presence of ions such as calcium[30], ammonium[31] and sodium[28, 3234].
2.2 Biochemistry of wounds
Purine metabolism (Figure 2.2) is known to play an integral role in tissue regeneration
and wound healing. Physiological wound healing requires energy in the form of ATP
(adenosine triphosphate).[35-36] With the degradation of purines in purine metabolism,
each step in the cycle generates a considerable amount of energy. This is known to grow
with increased apoptosis, leading to increased production of products in the pathway. In
turn, the terminal catabolite of purine metabolism in humans, uric acid, rises. This analyte
has been closely linked with relatively increased concentrations in the case of an injury,
when cells are increasingly dying.[37] Disturbance of the normal healing process of a
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wound, leads to sustained increased expressions of pro-inflammatory cytokines, linked
with increased UA.[38]

Figure 2.2 Purine metabolism in humans from apoptosis to excretion of Uric Acid

2.2.1

Biomarkers in wound care

2.2.1.1 Uric Acid
Uric Acid is the terminal product of metabolic breakdown of purine nucleotides,
Adenine and Guanine (Figure 2.2). It is a weak organic acid that, under normal
physiological conditions, exists mainly as a monosodium salt.[39] It is continually
produced by cells in the human body and is eventually excreted by the kidneys as a normal
component of urine. Known to form ions and salts called urates,[39] UA is a heterocyclic
compound of carbon, nitrogen, oxygen and hydrogen bearing the chemical formula,
C5H4N4O3 as illustrated by the distribution of atoms in Figure 2.3a.
The normal blood concentration of UA in humans varies between 0.1 and 0.4 mM
L-1. Elevated levels of UA have been correlated with its accumulation in kidneys as urate
stones and as crystals in joints, leading to gout. Increased concentrations of UA also lead
to hyperuricemia, joint inflammation, ischemia and increased risks of Type 2
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diabetes.[40y] Relatively higher UA concentrations are associated with 40 % increased
diabetic risks and 70 % increased renal risks. A specific consequence of diabetes is

(a)

(b)

Figure 2.3: Chemical structure of biomolecules (a) Uric Acid (b) Xanthine
neuropathy, which refers to the inability of neurons to send impulses. This reportedly
affects almost 60-70 % of diabetic patients.[41] This makes the timely assessment of
wound occurrence and its management a challenge. Many diabetics are thus inflicted with
chronic wounds, which bear huge socio-economic impacts in treatment management, along
with associated trauma from consequences of surgeries and amputations.[42]
Increased levels of UA, the product of human purine metabolism[43], is connected
with increased breakdown of nucleotides and cell death. This indicates its role as a possible
biomarker in wound care. Correlations between UA in the wound fluid and chronic venous
leg ulcers has been established. [44, 45] Chronic, non-healing wounds reportedly contain
elevated levels of UA, which lower with time as the wounds heal (Figure 2.4). Thus,
possible correlations of UA concentrations can be drawn from the healing of a wound
through its phases. POC techniques, which involve the detection of UA, can enable
quantitative assessment of a wound’s recovery.
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Figure 2.4: Correlation of Uric Acid concentrations with wound healing [243]
On the occurrence of a wound, UA levels are known to increase to about 0.2–0.7
mM L-1 from its normal concentration. With elevated concentrations around an injury,
this analyte can act as a potential biomarker to monitor healing progress from an injured
micro-environment. After phase one (hemostasis), when initial bleeding is arrested to
prevent further clots, new blood vessels start forming with tissue regeneration and
epithelialization of the extracellular matrix in second phase of inflammation. This is
followed by increased tensile strength of the matrix in phase three of proliferation with
re-modelling toward complete recovery from freshly healed dermal and epidermal skin
layers. Severity of a wound can be determined by the number of days a wound takes to
heal through its multiple overlapping phases, with increased chronicity being depicted
from higher concentrations of UA in phases of inflammation and proliferation. For
normal healing of wounds, the levels tend to gradually reduce, proceeding towards the
final phase of remodeling and complete recovery.[46] Across the different healing phases
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of a wound, UA levels are known to be higher in phases two (inflammation) and three
(proliferation). A chronic wound is known to have a slower healing rate over prolonged
inflammation with increased infection.
Besides blood, plasma (~ 0.3 mM), serum (0.2 mM–0.4 mM) and urine (250−750
mg/day), UA is also found in biofluids of sweat (~ 24.5 µM), saliva (0.1 mM–1 mM) and
tears (0.07 mM–0.1 mM), although in lower concentrations.[47-53] This allows for
possible non-invasive detection of UA. Different detection procedures of UA have been
investigated, but that for personalized wound monitoring, is still relatively in its infancy.
Primitive studies have suggested that detection of UA from wound exudate holds potential
for continuous monitoring of healing. Existing protocols explored for UA detection involve
optical methods of colorimetry or fluorometry, where either a fluorometric dye is used or
the differential absorbance of the reactant and product of its enzymatic oxidation are noted
at a certain wavelength (293 nm). Other approaches in detection involve chemical,
fluorimetry,

spectrophotometry,

chemiluminescence,

high

performance

liquid

chromatography and isotope dilution mass spectrometry.[54-58]
2.2.1.2 Xanthine
Xanthine is referred to as the cell housekeeper with major roles in cellular
metabolism through maintenance of cell redox potential, bacterial scavenging, infection
inflammation, antioxidant defense and system detoxification. Created from hypoxanthine
by xanthine oxidoreductase (XOR), xanthine (C5H4N4O2) (Figure 2.3b) is an intermediate
product of purine degradation. Its oxidation to UA is catalyzed by enzyme xanthine oxidase
(XO), a form of XOR which generates reactive oxygen species (ROS).
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In the case of cell rupture, xanthine is formed in the wound (localized xanthine)
from the breakdown of released energy of metabolites in damaged tissue. Inflammation is
a necessary response to tissue injury, leading to the production of ROS to mediate oxidative
stress, critical to normal wound healing.[60] Such species act as scavengers of oxygen
radicals to facilitate tissue recovery. Generated ROS from xanthine oxidation, can thus
alleviate healing and tissue repair.[59] Increased apoptosis increases XO activity thereby
raising subsequent metabolite levels. This suggests that wounds can thus be monitored until
closure through assessments of xanthine levels, to obtain an improved understanding on
healing.[61]
This bio-analyte is a purine base found in different human bio-fluids. Besides blood
(65 – 130 µM L-1), xanthine is also present in lower concentrations in other biological fluids
like plasma (1.4 µM)[62], serum (4.3–10.3 µM)[63], urine (~ 3.9 µM)[64] and tears[65].
This shows that potential non-invasive detection of xanthine is possible. Detection of
xanthine has been explored using different optical based methods like colorimetric and
fluorometric approaches whereby differential absorption of the analyte’s oxidation
reactant/product is analyzed at specific wavelength (570 nm). Mass spectrometric and
chromatographic techniques (HPLC) have also been explored to determine concentrations
of the analyte from different biofluid samples. [66, 67] However, techniques for detection
from biofluids associated with a wound milieu, are still on an anvil.
2.3 Monitoring the wound environment
Research into a wound milieu has shown that ambient parameters namely pH,
temperature and moisture from injured tissue environment, can offer indications of healing.
Some conventional real-time wound monitoring biosensors are reported in Table 2.1.
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All human biochemical processes are influenced by pH balance. Therefore, with pH as
an established health indicator, it can be correlated to cellular, protease activity and

Table 2.1. Comparison of conventional real time wound-care biosensors.[236]
bacterial infection. Monitoring the pH of a wound environment, can assist in evaluating
the underlying biochemical processes involved in tissue healing.[68-69]
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Wound occurrence shifts the pH of injured tissue region from normal, acidic levels of
healthy skin (4-6), to alkaline (7-9). As healing progresses, this pH is known to shift back
to acidic. Optical detection protocols have been investigated to monitor the pH of postsurgical areas. Electrical measurements have been performed using conductive thread
based diagnostic device platforms, to demonstrate subcutaneous pH shift of a wound
environment from physiochemical tissue properties. [70] A novel smart bandage designed
by Empa Inc. reportedly alerts nursing staff on adverse healing through optical detection
(Figure 2.5d). Optical sensors incorporated into a bandage demonstrate qualitative tracking
of healing, from pH variations of injured tissue area, utilizing fluorometric techniques to
glow at different intensities based on wound severity.[71] This does not involve
unnecessary dressing change to monitor healing, leaving it undisturbed from orientation
and position. This gentle therapy of fluorescence sensing intends to provide continuous
wound care to patients from home, without having to change dressings more frequently
than necessary. However, this does not provide quantitative measures of wound healing
progress.
Temperature is a factor known to be associated with inflammation. On the
commencement of a physical injury, the temperature in wound milieu can reportedly
increase from normal body temperature by > 2 0C.[72, 73] This increased temperature is
an indicator of increased infection and inflammation.[69] The difference in temperature
from normal, disturbs optimal metabolite functionality in the body, thus creating
differences in the involved biochemical and metabolic pathways. This can delay and slow
down healing progress.[74] As a wound heals, normal physiological temperature is
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gradually attained, promoting optimal functioning of bio-analytes, contributing to tissue
recovery.
Optimal moisture balance is essential for tissue healing, as too wet of an
environment can lead to maceration, while too little can desiccate it.[75] Attention has been
given to the moisture condition of a wound milieu at the time of dressing change.
Commercial WoundSense moisture sensor has been reported to observe the wound
moisture status, without disturbing or removing the dressing (Figure 2.5e).[76] Studies
from different kinds of chronic wounds (diabetic foot ulcers and pressure ulcers), have
shown that this system can alert a patient for a dressing change based on optimal moisture
levels of the wound environment.[76] This device targets to improve wound management
from impedance responses of the sensor, based on shifts in moisture content of the wound.
Tracking bacterial and microbial infection is also considered for appropriate drug
therapy, using optical approaches.[77-78] Although these methods claim to determine
oxygen measures from a laceration through correlations of optimal tissue oxygenation,
these are not directly reflective of recovery status. These correlations are unsuitable for
continuous monitoring of tissue recuperation and being incapable of providing direct
quantitative measures of healing, cannot be considered for precise evaluation of wound
chronicity. A medical breakthrough, that can quantify the healing of injured tissue from
longitudinal measurements of specific bio-analytes and enable continuous tracking of
wound healing progress, is yet to come. Detection of specific biomarkers of healing, can
assist in overcoming some existing limitations in wound care through direct provision of
quantifiable measurements from relevant analyte concentrations. This can potentially
enable to improve the efficacy of wound management.
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2.4 Current state-of-the-art in wound care
Current wound therapy involves frequent clinical trips for treatment management.
Assessment of healing is only achieved at the time of dressing change through visual
inspection. Imaging solutions like those from eKare Inc. [79] provide information on
healing from 3D measurements of a scanned image collected from the wound area. The
wound is optically mapped to a visual interface to obtain its physical dimensional

(b)

(a)

(c)

(e)

(d)

Figure 2.5: Existing protocols in wound management offering qualitative assessment
from (a) visual inspection [80], (b) wound imaging[80]; and (c) wound mapping[242];
(d) pH monitor from Empa Inc. for tracking healing of wounds[71]; (e) Wound moisture
monitor from WoundSense[77]
measurements. Aranz Medical Inc. uses laser technology, to scan the wound surface area
and monitor healing progress over time.[80] Paper based scales are also available for
tracking wound height and width to determine healing through reduction in geometric
dimensions and physical parameters. [81- 82] These methods are illustrated in Figure 2.5(ac). However, these conventional practices allow for one-time measurements and offer
qualitative assessment. They are not suitable for continuous monitoring and do not offer
20

convenient compliance with treatment protocols, with inefficient management of wound
dynamics in real-time.
2.5 Mechanisms explored in detection of wound biomarkers
An overview of the approaches utilized in detection have been enlisted below:
i.

Colorimetry – Colorimetric approaches in optical detection are used for determining
purine metabolites like UA and xanthine. Such procedures for assays in serum and
urine have been previously investigated. Morphological transition of Ag nano-prisms
at a specific wavelength can be used to determine UA concentrations from a color
change through a shift in surface plasmon resonance spectral band.[83] Microfluidic
paper-based analyses have also shown bi-enzyme colorimetric detection of different
concentrations in human serum samples. With enhanced sensitivity, change in color
signal has enabled detection from small volumes.[84] Such platforms have provided
improved color uniformity and intensity for sensitive and selective determination of
UA, from co-immobilization of chromogenic reagents (tetramethylbenzidine, TMB)
generating a colored product, also enabling detection at lower limits (1 µM).[85]
Colorimetric studies from palladium (Pd) nanoparticles supported on nitrogen and
sulfur doped nanostructures with TMB have provided efficient detection of Xanthine
and offered information form urine concentrations.[86] This method used to evaluate
Xanthine in urine and serum samples was seen to provide good stability.[87]

ii.

Fluorimetry – Fluorescent sol-gel biosensors have been designed for determining
concentrations in urine, serum and blood. With detection limits as low as 20 nM, studies
have shown reliable determination from diluted biological fluids in presence of
interfering species.[88] Approaches have been used to understand the fluorescent
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reaction between UA/Xanthine and a fluorometric reagent in the presence of hydrogen
peroxide (H2O2) and TRIAP (1,1,3-tricyano-2-amino-1-propene), which generates a
fluorescent product at a specific wavelength, observed from their respective excitation
and emission spectra.[89] Fluorometric assays for determining analyte concentrations
in serum and urine have been shown using direct reaction rate methods. Consumption
of dissolved oxygen at a certain potential has been correlated with the analyte’s
presence. Fluorometric assays have reportedly demonstrated good sensitivity to
Xanthine in tissue.[90]
iii.

Spectrophotometry – Catalytic activity of the specific enzymes can be studied from
enzyme functionalized substrates using spectrophotometry. Radiation grafting of
functional polymers, supported the design of an optical biosensor to sense shifts in
UA/Xanthine concentrations, in the micro-molar range (<200 µM), in aqueous
solutions. This was observed from the SPR band of its UV-Vis absorption spectra in
presence of varying concentrations.[91] Spectrophotometric investigations were
conducted for detection of purine metabolites in serum samples, depicting a correlation
of 0.9. This study reportedly provides excellent specificity with minimal
interference.[92] Such techniques have shown improved sensitivity over other
conventional methods. This can be applied to purine metabolite assays for human
serum and urine.[93] Enzyme XO activity was monitored in human plasma using a
spectrophotometric assay using ferricytochrome c.[94] Fourier transform infrared
(FTIR) spectrophotometry has shown the possibility of Xanthine detection using such
approaches.[95-96] Multivariate statistical tools have also been used for detection of
UA and Xanthine in bio-matrices of human serum and urine. [93]
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iv.

Chemiluminescence – Chemiluminescent methods using flow injection (FI) are being
developed to determine concentrations of these bio-analytes, based on the enhancement
in chemiluminescence intensity of certain compounds in presence of the specific
compound. This method was tested with clinical samples of human serum and urine,
targeting diagnosis and therapy of patients with disorders such as gout, hyperuricemia
and Lesch-Nyhan syndrome, associated with elevated levels of UA.[97] A novel paper
based microfluidic platform employing chemiluminescence to detect UA shows a good
shelf life, approximately 10 weeks, when stored after single use at 40C. This reports the
successful integration of chemiluminescence and a microfluidic paper-based analytical
device for an economical, simple-to-use, portable biosensor for low-volume
determination.[98] Fiber optic sensors were designed for detection of xanthine based
on such methods, from peroxide generated by the reaction of xanthine with luminol
and peroxidase. These showed good recovery between 91 and 102 % from analyzed
samples.[99]

v.

Mass spectrometry – Specific liquid chromatography-tandem mass spectrometry has
been investigated for determination and quantification of intracellular and extracellular
purine metabolites in urine. Low detection limits of approximately 0.07 mg dL-1 were
obtained for UA with a correlation of about 0.9.[100] Techniques of isotope dilution
mass spectrometry have been investigated to detect such analytes in serum. The
accuracy of obtained results was evaluated with certified values from gas
chromatography/mass spectrometry (GC-MS) reference methods.[101] Similar
detection methods by liquid chromatography-electrospray tandem mass spectrometry
have allowed detection of xanthine from urine samples.[102] XOR activity can also be
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monitored in serum samples using liquid chromatography/triple quadrupole mass
spectrometry methods.[103]
vi.

High performance liquid chromatography – HPLC technique has been employed to
quantify such purine metabolites as pharmacodynamic biomarkers.[104] Detection in
human urine has been noted to provide a detection limit of 0.1 µg ml-1, with a recovery
of approximately 95%.[105] Determination of such analytes in human urine using ion
chromatography, have shown detection limits of 0.5 µg L-1.[106] Xanthine detection
was performed using HPLC to assess feasibility of detection in plasma and erythrocyte
samples.[62] Serum sample analyses for multiple purine metabolites showed good
recovery (86 - 93 %) using such approaches.[107]

2.6 Electrochemical determination of wound biomarkers
Electrochemical biosensing provides for cost-effective detection with greater
simplicity and improved sensitivity.[43] This technique can offer excellent electrochemical
activity towards detection of UA and Xanthine, with potential application in determining
their concentrations in bio-matrices of serum, urine and plasma. Such detection entails
investigating the analyte’s oxidation/reduction mechanism in their metabolic pathway,
whereby the concerned specific enzymes catalyze the undergoing reaction to generate H2O2
as a by-product. Yield of the generated by-product, H2O2 can be utilized to quantify UA
and Xanthine. [108] Among electrochemical sensing modalities used for UA/Xanthine
detection, potentiometric (cyclic voltammetry, linear voltammetry, square wave
voltammetry and differential pulse voltammetry) and amperometric/chronoamperometric
methods have been explored.[109-118]
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Specific detection for UA and Xanthine is attained from utilization of enzymes
UOx and XO, to explore their respective oxidation pathways as shown in Eq. 1 and 2.
These enzymes act as natural catalysts enabling detection through a natural biological
process.
𝑋𝑋𝑋𝑋𝑋𝑋𝑋𝑋ℎ𝑖𝑖𝑖𝑖𝑖𝑖 + 𝐻𝐻2 𝑂𝑂2 + 𝑂𝑂2 → 𝑈𝑈𝑈𝑈𝑈𝑈𝑈𝑈 𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴 + 𝐻𝐻2 𝑂𝑂2

𝑈𝑈𝑈𝑈𝑈𝑈𝑈𝑈 𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴 + 𝑂𝑂2 + 𝐻𝐻2 𝑂𝑂 → 5 − ℎ𝑦𝑦𝑦𝑦𝑦𝑦𝑦𝑦𝑦𝑦𝑦𝑦𝑦𝑦𝑦𝑦𝑦𝑦𝑦𝑦𝑦𝑦𝑦𝑦𝑦𝑦𝑦𝑦 + 𝐻𝐻2 𝑂𝑂2

..... (1)
..... (2)

Enzymatic detection helps to address some existing challenges associated with
elaborate sample collection and preparation procedures, along with prolonged detection
time and analyses, associated with existing protocols that are limited to laboratories and
deter the successful commencement of effective biosensing. Such approaches can
potentially target quantitative monitoring of biomarkers at a miniaturized and costeffective scale. These methods possess the ability to move away from discrete lab-based
sensing methods, advancing toward personalized, convenient therapy.
2.7 Nanomaterials employed in electrochemical detection of wound biomarkers
Different sensors based on nanocomposite materials have been designed for
electrochemical bio-analyte detection. This has been seen to significantly improve sensing
performance in terms of sensitivity.[119] Conductive substrates made functional with
infused nano-material, have been seen to improve sensitivity through superior
conductivity, higher electroactive area and surface-volume ratios. This facilitates
accelerated electron transfer between the analyte and the transducer on account of
increased binding sites and surface interactions. An overview of the different materials
explored in enzymatic UA detection is illustrated in Table 2.2, with a summary of the
sensing performance.
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Different metal (Pt/Cu/Zn/Ag/Ca/Sn/Au/Al) and metal-oxide (ZnO) based
nanomaterials have enabled superior sensing performance in UA and Xanthine
detection.[120-124] The offered large surface area from distribution of the nanomaterial
across the electrode surface, increases electrical conductivity and electrocatalytic
properties of the surface.[125-127] This provides significant mechanical strength to
facilitate rapid electron transfer between the analyte and the transducer. [6] Platinum-nickel
(Pt-Ni) nanocomposites and carbon based metal (Co/Ni/Ce/) nanocomposites have also

Table 2.2 Comparison of materials employed in enzymatic Uric acid determination
using UOx functionalized electrochemical biosensors. RT represents room temperature
[236]
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been explored in UA detection,[128-130] offering linear, reproducible response with good
specificity. The incorporated nanomaterials offered superior catalytic activity and
enhanced sensitivity with lower detection limits, as displayed by the study.
Most acclaimed materials used in UA detection involve nanoparticles of carbon (C)
and gold (Au). Synthesis of specific nanostructures (dots, fibers, tubes, wires, rods, sheets,
etc.)[128, 131-135] from graphene and graphene oxide (GO), are known to enhance
electrochemical sensing response. Such nanomaterials have also been reported to enable
enhanced response in Xanthine detection offering rapid response in less than 2 min.[136]
Single-walled carbon nanotubes (SWCNT), double-walled carbon nanotubes (DWCNT)
and multi-walled carbon nanotubes (MWCNT) have been explored in detection of
Xanthine and noted to record linear response in concerned physiological ranges.[137-138]
Gold nanoparticles (AuNP) are widely used to allow for improved detection
through increased surface interactions and higher surface-volume ratios. Exhibiting good
biocompatibility, its inclusion in the design of a biosensor provides a suitable
microenvironment for biosensing. In addition to offering increased conductivity, it assists
in maintaining the redox potential of the undergoing reaction with good electrochemical
stability. With portrayed good electrical properties, presence of Au nanocomposites
facilitates enzymatic detection, reducing the insulating effects of involved proteins to
enable direct electron transfer through a conductive channel.[139-140] Specific structures
of AuNP have been noted to reduce the thickness of the double layer formed on the
transducer in detection, and offer improved electron transfer from reduced distance
between the transducer and the analyte. Nanocomposites of carbon and gold have also been
reported to enable detection of Xanthine at lower potentials.[141-142]
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Specific structure and morphology of such material at the nanoscale enables superior
sensitivity owing to augmented ionic interactions offered from large surface-volume ratios.
Such materials are reported to improve sensing performance and enable detection at
specific potential in relevant physiological ranges.
2.8 Substrate materials explored in wearable biosensing
Different flexible materials have been explored in the design of wearable biosensors.
Ongoing attempts in the synthesis of flexible biomaterials target the use of stretchable
materials that are biocompatible and conformal to the skin surface, so that they can be
integrated into body-borne form factors. Various configurations for wearable sensor
designs have been conceptualized for collecting valid information from different
physiological parameters (heart and breath rate, wrist pulse, facial expression, vocalization
and metabolism). However, their development in the medical space has been slow and their
reliability for continuous monitoring in real-time is still an unconquered challenge. This
can be attributed to the consideration of several factors involving biocompatibility,
compactness with skin, durability, size and weight.
The implementation of health solutions in convenient and economical formats has been
marked by the advent of flexible, soft materials. Paper based analytical tools (glucose
strips/pregnancy strips) are being explored as an attempt to shift lab-based diagnostics
toward POC.[143] Organic membranes of carbon or other metals demonstrate stretchable
properties, which can be employed in the detection of limb/body motion. These, however,
do not provide a comfortable setting to translate human gestures from related
measurements of pressure or strain. Tape and tattoo-based sensors have been investigated
to identify specific facial expressions from muscle movements. Biocompatible and
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mechanically invisible tattoo electronics, explored as an epidermal platform for high
performance electrical measurements, have offered repeatable, continuous measurements
in wellness management.[16]
Attuning the electrical and mechanical properties of such different kinds of conducting
and semiconducting materials allow for improved stretchability and electrical conductivity
in seamless and robust transduction of physiological parameters. Flexible polymer
materials, among others, are investigated because of their immensely adjustable
physiochemical properties. PDMS is a widely used silicone elastomer which is used as
wearable substrate material, due to its biocompatibility and low elastic modulus. Its nontoxic, non-flammable and hydrophobic properties, along with good processability, has
allowed its use in wearable sensing devices.[16] Other flexible elastomers that are gaining
popularity are rubber-based silicone in EcoFlex, DragonSkin and Silbione, which are
known for their use in flexible implantable sensors due to their biocompatibility and
chemical inertness. These have been reported to show superior deformability and
conformability on surfaces with varied textures and geometries, rendering their compliance
to wearable biosensing.[3]
Polycarbonate (PC), polyethylene (PET) and polyimide (PI) films are also gaining
diversity as substrate materials because of their high stretchability, thermal stability and
ease of printability.[3, 144] Other organic polymer materials and co-polymers involving
poly

(3,4-ethyl-enedioxythiophene-poly(styrene-sulfonate))

(PEDOT:PSS),

Polyvinylidene fluoride (PVDF), Polytetrafluoroethylene (PTFE), Polyaniline (PANI) and
polymethyl methacrylate (PMMA), are investigated as solid-state physical sensing
platforms owing to their tunable electro-mechanical properties, thermal stability and
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electrochemical inertness. Liquid-state materials are also being examined for designing
flexible diagnostic platforms, with exciting applications in personalized health analyses.
Utilizing the signal transduction mechanism from mechanical deformations, this employs
ionic liquids in the form of metallic alloys from eutectic mixtures of gallium-indium
(eGaIn) and Galinstan.[145] This has allowed for advancements in numerous biochemical
assays due to their superior sensing performance from low sample volumes, reduced
fabrication costs and low power requirements. They claim to offer a more robust platform
for wearable biosensing, as fundamentally liquids are more deformable than solids.[145]
To promote wearability, efforts are directed to cater to the bending, stretching and
twisting of joints and skin which can induce curvature related variations to the response.
Fabric and cellulose based material like cotton and other textiles are being investigated as
platforms in wearable health monitoring. Conductive textiles are being adopted in apparel
like gloves, socks and other clothing to demonstrate their potential in wearable
diagnostics.[3, 146-147] Significant research is conducted to integrate conductive fibers
such as thin filaments or metallized textile yarns, which can be woven, knit or sewn onto
consumable wearables. Such forms of electronic textiles are gaining popularity owing to
their versatility and robustness to sustain mechanical variations. These materials can be
engineered to miniaturized bendable form factors for the potential integration of sensors
onto a wearable construct. This attempts to achieve conformal contact on skin-like
curvilinear surface of the human body for personalized wellness management at POC.[148]
2.9 Design of wearable biosensors
Different flexible sensing platforms have been explored in enzymatic electrochemical
detection of biomarkers. Advancements are being examined with flexible interconnects
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and fibers used in conjunction with graphene based functional materials[149] using
different fabrication techniques like drawing or printing.[150] Among the different
methods used to fabricate electrodes on textile based material, screen-printing is among the
most widely used, easier methods. Other procedures include inkjet-printing, roll-to-roll
printing, gravure printing and laser direct write printing. An overview of these methods is
elucidated below:
Screen printing – This is a method, where printing on a substrate, is achieved using a screen
of specific mesh size to achieve required resolution. This allows transfer of ink onto a
substrate, excluding the areas which have been masked from it using a stencil. A squeegee
is used to fill the open mesh apertures with ink, while the mesh screen is in contact with
the substrate.[151] Screens are usually made of polyester or stainless steel. The selection
of material and mesh count are important for obtaining optimal resolution in printing, based
on the particle size and composition of ink used.
Inkjet printing – Inkjet printing is a form of digital printing and is used in digital graphic
design, whereby a digital image is created by propelling ink drops onto the substrate. Inkjet
printers use solvent-based inks from volatile organic compounds (VOCs) that are cured
when exposed to UV light. They provide the advantages of cost-effective printing and good
durability. However, use of solvents in their composition increases diffusion capability of
the ink when it is used for printing on flexible textile material.[152]
Roll-to-roll printing – Widely known as roll-to-roll processing, this method is used for
flexible electronic devices and entails printing or applying coatings on a roll of flexible
material. Thin film based electronic circuits can be patterned onto large, portable substrates
using this method.[153]
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Gravure printing – This kind of printing is a high speed roll-to-roll printing method which
involves engraving an image onto an image carrier, acting as a rotary imaging press. The
image carrier transfers ink to an impression roller, which then transfers it onto desired areas
of the substrate. The substrate is sandwiched between the carrier and the impression roller,
ensuring proper contact of the substrate with the carrier from applied force of the roller.
This ensures even and maximum coverage of ink for a uniform coating. [154]
Laser printing – Laser printing is an electrostatic digital printing method which can
produce high quality text and graphics from a laser beam. The beam is passed over a
charged image carrier which selectively collects electrically charged ink particles and
transfers it onto the substrate. This is followed by heating to affix the print onto the
substrate. Using the principle of photoconductivity, the ink particles are attracted to the
carrier, transferring the image onto the substrate by direct contact using raster printing.
[155]
For wearable wound diagnostics, detection of biomolecules is explored on soft,
wearable, healing material like cotton gauze. Feasibility of biomarker detection from such
a platform can be employed in personalized wound diagnostics for continual management
of healing, as and when necessary. Such design shall eliminate the unnecessary
paraphernalia of bulky equipment, which make it non-conformal to damaged skin.
Electrochemical characterizations have been conducted on nanomaterial based enzymatic
sensors designed to quantify changes in UA and Xanthine concentrations from different
biofluids of injured patients.
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CHAPTER 3
ENZYMATIC BIOSENSOR FOR STABLE DETECTION OF URIC ACID BY ENTRAPMENT IN
PVA-SBQ POLYMER MATRIX
In this chapter, electrochemical approaches using UOx as an enzyme to detect UA for
wound monitoring have been reported. UOx was entrapped in a cationic polymer matrix,
poly (vinyl alcohol) N-methyl-4(4’formylstyryl) pyridinium methosulfate acetal (PVASbQ), and response stability over multiple days was assessed. Stability of enzymatic
detection under physiologically relevant variations of temperature and pH were explored
from the enzyme entrapped in the polymeric matrix. A redox electron shuttle, ferrocene
carboxylic acid (FCA) was utilized to facilitate accelerated electron transfer and investigate
electrochemical performance. Sensor response was recorded using voltammetric
techniques to measure UA within physiologically relevant ranges.
3.1 Enzyme Uricase, UOx
UOx is an enzyme that plays an integral role in the catabolic metabolism pathway of
humans. With no metal or organic factor required for catalysis, UOx is made of 303 amino
acid residues, 15 of which are involved with the active site.[156] Among these residues,
Leu170 forms a hydrophobic floor beneath the substrate and plays a role in its positioning.
Three of the conserved residues (Arg176, Val227, and Gln228) within each active site act
as ligand tweezers to bind and hold the substrate in place. Within the active site, Asn254
from one monomer and Thr57 from another hydrogen, bond a single water molecule,[157]
assisting in specific UA oxidation.[115] Selective oxidation of UA occurs in four identical
active sites of the enzyme’s quaternary structure, located at the interfaces between its four
subunits.[158]
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3.2 Effect of physiological pH on Uricase
A key factor that influences wound healing is pH of the area surrounding the bruise.
Chronic non-healing wounds are known to have an alkaline pH (7.15 to 8.9). As healing
progresses, the pH becomes more acidic, approaching that of normal skin (4–6). The pH
of different biofluids namely blood, serum, urine, saliva and sweat are slightly acidicneutral (5–7) [74, 159]. Since enzymes can only function in a specific pH environment; it
was necessary to assess the activity of UOx in various pH environments. This can also
provide an understanding of how a wound’s severity changes with time.
Enzyme UOx is known to be active in alkaline environments between pH 8 and 9, with
lowered activity as it deviates beyond. To evaluate the effect of pH, UOx was studied from
pH 5 to 10 using absorption spectroscopy. Specific activity of UOx was calculated from
the absorption values and plotted in Figure 3.1. Higher activity of UOx (4.3 U mg-1 ) was
recorded at pH 7.8 which elevated response in the pH region between 7 and 9.
Electrochemical analyses were performed over different pH to assess the change in

Figure 3.1 Comparison of pH effect on specific activity of UOx and current density of
UOx electrode [236]
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response of UOx electrode. As noted from Figure 3.1, higher current density of about 120–
130 mA cm-2 was observed between pH 7 and 9, beyond which lower response was
attained. These investigations provide an improved understanding of the pH environments
suited for enzymatic UA detection. With higher response obtained at pH 7.8, this was
chosen as the optimum pH for subsequent studies using a UOx based sensor, described in
the following sections.
3.3 Enzyme immobilization protocols in detection of Uric Acid
In enzyme electrochemistry, the immobilization technique determines enzyme loading
and stability. Existing immobilization approaches include physisorption, entrapment,
encapsulation and crosslinking.
Physisorption provides for a simple and cost-effective method in direct immobilization.
Although, it shields agglomeration and provides for uniform loading across the sensor
surface, the enzyme affixes through hydrogen bonds, electrostatic and weak van der Waal’s
interactions. This could lead to leaching of the enzyme and reduced enzyme activity.
Entrapment is a method where the enzyme is confined within a certain hydrogel or
polymeric matrix. It is entrapped through covalent and non-covalent bonds offering
improved stability, reduced denaturation, retainment of enzyme activity and its
electrocatalytic properties.
Encapsulation involves enzyme enclosure within a semi-permeable polymer membrane.
Although this provides stable response and good repeatability, the thin interface can cause
enzymes to leach.
Crosslinking entails immobilization of the enzyme with the help of a suitable crosslinker
which firmly binds the enzyme onto the transducer surface through covalent bonds.
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However, this method does not allow for increased loading and can alter enzyme
orientation while binding with linker molecules, with conformational changes at the active
site. Such structural changes at the active site can cause response to degrade from lower
enzyme activity and leaching.
In enzymatic UA detection, entrapment and encapsulation of the enzyme UOx have
been investigated using different polymeric matrices of PANI, polypyrrole and PVC,[160163] or gels like chitosan, silica and collagen.[88, 164-165] Ionic polymers have also been
reported to provide enhanced sensitivity and stability.[166-167]
3.3.1

Uricase entrapment in PVA-SbQ polymer matrix

In this work, enzymatic electrochemical sensors in which UOx was either physisorbed
or entrapped in PVA-SbQ, a cationic polymer, were investigated in UA detection. The
amine group of the styrylpyridinium side chains in the PVA backbone offers firm
attachment to immobilize the enzyme to the electrode surface.[168-170] This is due to the
net charge of the enzyme being partially negative (𝛿𝛿 − ) above pH 7.5. The pKa and the

Figure 3.2 (a) PVA-SbQ interaction with negatively charged amino acid chains of UOx
enzyme, (b) Inset depicts structural interactions between the carboxylic functional
group of the enzyme and the amine side chains of the polymer [236]
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isoelectric point values of UOx are 4.64 and 7.5 respectively.[163] The binding and
interaction of the amino acid chains of UOx with the polymer is depicted in Figure 3.2 a
and b, with the polymer structure in the schematic having minimized bond energy.
Use of PVA-SbQ for improved stability and shelf life of UOx based enzymatic
biosensors have been investigated in this study. This biocompatible polymer has an edge
over others with its protective effect and the advantage of providing biosensors with a
longer lifetime.[171-172] Stability studies for PVA-SbQ showed that the polymer is stable
over multiple days (Figure 3.3).

Figure 3.3 Plot representing stability of the pristine PVA-SbQ obtained from continuous
measurements for n=4 over multiple days with RSD of 0.41 [236]
3.4 Ferrocene Carboxylic Acid as a mediator in Uric Acid detection
It is known that enzymes have deeply buried active sites and diffusion of reagents to
the electrode surface can be limited.[173] As electron transfer decays exponentially with
increased distance,[171] weaker response may be obtained for lower concentrations. In the
design of second-generation biosensors, this limitation is being overcome with the use of
mediators which provide improved response from the reaction on the transducer. The use
of a redox electron shuttle as a mediator in enzymatic UA detection facilitates improved
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electron transport between the active site of the enzyme and the electrode, offering
enhanced

response.

ferricene/ferrocene

Such

and

mediators

include

methyl/methoxy

derivatives

compounds.[174-176]

of

benzoquinone,

Ferri/ferro

based

compounds require lower energy for the redox reaction, enabling detection in a lower
potential window with minimized interference from other electro-active species.
Electrochemical voltammetric investigations have shown ferrocene and its derivatives
(ferricinium ion forms) to be electron acceptors for specific enzymes and molecules.[177]
This addresses the limited diffusion rates seen in first generation biosensors, providing
improved signal with minimized interference from dissolved oxygen in produced H2O2.
Ferrocene Carboxylic Acid (FCA) has been used in this study as a mediator to aid
accelerated electron transfer between the active site of the enzyme and the transducer
surface.
3.5 Experimental
3.5.1

Materials
Lyophilized UOx powder containing 15-30 U mg-1 of UOx was purchased from

Sigma Aldrich. The electron transfer mediator FCA was purchased from Chem-Impex
International, Inc. PVA-SbQ purchased from Polysciences, Inc., was used to entrap UOx
on standard screen-printed carbon electrode (SPCE) purchased from CH Instruments, Inc.,
United States. UA, H2O2, sodium phosphate monobasic (NaH2PO4) and sodium phosphate
dibasic (Na2HPO4) and boric acid used were of analytical grade. All aqueous solutions
were prepared using deionized (DI) water. Phosphate buffer (20 mM) and boric acid (20
mM) were used as electrolyte solutions. Phosphate buffer solutions (PBS) (pH 5 to 7.8)
were prepared using NaH2PO4 and Na2HPO4 salts. Boric acid buffer solutions were
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prepared for pH 8 to pH 10 solutions. 0.2 U ml-1 horseradish peroxidase (HRP) and 50 mM
Amplex red reagent, of analytical grade were used from ThermoFisher Scientific, for
fluorescence studies. All other chemicals used were of analytical grade.
3.5.2

Apparatus and Methods
Cyclic voltammetry (CV) and differential pulse voltammetry (DPV) were

performed using the CHI-230B potentiostat from CH Instruments, Inc. Electrochemical
characterizations of the enzymatic electrode were carried out in a conventional three
electrode cell assembly consisting of Ag/AgCl as reference electrode and Pt wire as counter
electrode. The working electrode was either bare SPCE or modified SPCE. The SPCEs
were modified with (i) PVA-SbQ (polymer), (ii) UOx (physisorbed), and (iii) UOx in PVASbQ (entrapped).
Effect of pH variations on enzyme activity was analyzed using Evolution 201 UV
Visible Spectrophotometer, ThermoFisher Scientific. Material characterization studies of
the electrode surface were performed using Raman spectroscopy with a 514.5 nm Ar laser,
and impedance measurements were conducted with Gamry impedance analyzer. Scanning
electron microscope (SEM) JEOL 6330, ThermoFisher Scientific and Nikon C1 confocal
microscope (Nikon Instruments Inc., Melville, NY) were used to obtain images of the
enzymatic sensor surfaces. This provided an understanding of optimized polymer-enzyme
loading for robust immobilization toward improved stability. Entrapped sensor response
was investigated over multiple days under physiologically relevant variations of pH and
temperature. Electrochemical analyses were conducted to study repeatability,
reproducibility and shelf life of the entrapped sensor.
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3.5.3

Enzyme Immobilization
Prior to immobilization, SPCEs were polished with 0.05 mm alumina slurry and

rinsed thoroughly with DI water. PVA-SbQ solution was prepared with DI water in a ratio
of 2.5:0.5 [V/V], while 0.5 U cm-2 UOx was prepared in 1 ml PBS buffer solution (pH 7.8).
All enzyme immobilizations were carried out by drop casting, nitrogen drying, and then
vigorously rinsing in buffer prior to testing. Enzyme loading studies were carried out by
keeping the volume of PVA-SbQ constant and varying UOx [V/V] in the ratio of 1:2 (53.2
µg cm-2:0.25 U cm-2), 1:4 (53.2 µg cm-2:0.5 U cm-2) and 1:6 (53.2 µg cm-2:0.75 U cm-2).
Vigorous rinsing was done to remove excess unbound enzyme. Drying in nitrogen enables
removal of excess water from the electrode surface, forming a gel like structure. These
immobilization steps were carried out in an ice box to prevent enzyme denaturation and
leaching. In physisorption, 0.25 U cm-2 UOx was drop casted on the bare SPCE and dried
in nitrogen in an ice box for 10 min. For fluorescence studies, the electrode was
immobilized with polymer and UOx in different ratios as discussed. 20 U ml-1 HRP was
then immobilized on the electrode in the polymer UOx matrix. In the presence of 1 mM
UA with 50 mM amplex red, fluorescence was investigated at 570 nm.
3.6 Entrapped enzymatic biosensor surface characterization
UOx entrapped in PVA cationic polymer on the electrode was characterized by
spectroscopic, optical and electrochemical techniques to assess the sensor surface
morphology and characteristic behavior. Physisorbed UOx on the electrode surface was
used as control in these studies. To obtain highest loading of UOx on the electrode surface,
various ratios of polymer and UOx (1:2, 1:4 and 1:6) were studied.
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Raman spectra of proteins consist of bands associate with its peptide chains. This
technique offers several advantages for analysis of enzymes through the shifts in peak and
intensity. The structural fingerprint of specific molecules in entrapped UOx-PVA-SbQ was
assessed using a continuous wave (CW) argon ion (Ar+) laser (model 177G02, Spectra
Physics) of 514.5 nm excitation. The spectrum exhibited in Figure 3.4a depicts two main
zones at intermediate (1,100–1,400 cm-1) and high (1,500–1,700 cm-1) frequencies. While
a polymer functionalized electrode provided typical peaks at 1330.8 cm-1 and 1613.72 cm1

due to -CH and -OH interactions, amine in the pyridine of PVA-SbQ showed bands at

1184.34 cm-1 and 1214.34 cm-1. Minute shifts in these peaks were observed for UOx
functionalized electrodes, with the polymer chain interactions noticeably overshadowing
the amino acid chain interactions of UOx. The entrapped enzymatic electrode provided
distinct peaks for amide III band of UOx and phenylalanine at 1324 cm-1 (Figure 3.4b) and
1116.99 cm-1 (Figure 3.4c) respectively. This can be attributed to C-C and -C-O-C bonds
and changes in the 𝛼𝛼- helical structure and 𝛽𝛽 -sheets of the enzyme due to electrostatic

Figure 3.4 Raman spectra of UOx functionalized substrates measured with 514.5 nm
Ar laser. (a) Polymer-UOx ratio 1:2 in (—) red line, 1:4 in (- - -) dashed purple line, 1:6
in (—) green line, UOx physisorbed in (—) dark blue line and pristine polymer in (—)
purple line. The red, purple, green, blue bands represent the groups in PVA-SbQ. (b)
amide III (red band) and (c) phenylalanine (green band) groups in polymer-UOx
functionalized substrate [236]
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interactions between 𝛿𝛿 - of the amino acid chains and positive charge of pyridine in PVA-

SbQ. As compared to physisorbed UOx, a slight shift of the amide I band is seen from
1578.78 cm-1.

Other amino acid residues like leucine, valine and arginine also provided smaller
intensity peaks at 772, 1037, 1339 and 1569 cm-1 representing stretching vibrations of CH, -NH and -CN bonds of the carboxyl and amino groups in the UOx functionalization
matrix (Figure 3.5). These results conform with those previously examined for these groups
[178-180]. Copper, being embedded within the amino acid chains, displayed a relatively
small peak around 985.7 cm-1.[181] In Figure 3.5a there was a decrease in intensity of the
predominant polymer peaks as the UOx volume increased (polymer: UOx ratio in electrode

Figure 3.5 Raman spectra of UOx functionalized substrate measured with 514.5 nm Ar
laser, showing peaks of amino acid residues depicting bonds of (a) C-C (yellow band)
and (b) CO2- (orange band) in Arginine; (c) C=C and -CH3 in Valine (green band); and
(d) -CO2- (blue band) in Leucine. The dashed purple line is the signal from pristine
PVA-SbQ [236]
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preparation). This decrease was due to reduced polymer concentration on the electrode
surface.
Fluorescence microscopy was performed to elucidate the morphology of the UOx
entrapped matrix and to visualize the UOx reaction. Along with physisorbed, the effect of
three different enzyme ratios of 1:2; 1:4 and 1:6 in the hybrid PVA-SbQ/UOx system were
investigated. In these studies, amplex red was used as a fluorescent tag for imaging
immobilized enzyme on the electrode surface. On enzymatic oxidation of UA, amplex red
reacted with the formed byproduct, H2O2 in the presence of HRP to form fluorescent
product, resorufin at 570 nm. Results (Figure 3.6) offered a pictorial representation of the
entrapped enzyme on the electrode surface. Increased UOx volume (polymer enzyme ratio)
from 2 mL (1:2) to 6 mL (1:6) (Figure 3.6a–c), led to more un-entrapped enzyme leaching
out during electrode preparation procedures suggested by the formed dark empty spaces,
depicted by yellow arrows in Figure 3.6. In 1:4 and 1:6 ratios (Figure 3.6b and c), the
enzymes were scarcely populated compared to the 1:2 ratio (Figure 3.6a). Leaching from
higher V/V ratios is accredited to reduced cation to anion ratio in 1:4 and 1:6 matrices as
compared to 1:2. This did not allow for firm entrapment of the enzyme within the interface

Figure 3.6 Fluorescence microscopic images of UOx functionalized substrates with
various polymer-UOx ratios of (a) 1:2; (b) 1:4; (c) 1:6; Yellow Arrows indicate vacant
spaces from reduced loading and low distribution of enzyme across sensor surface; and
(d) physisorbed; (e) depicts comparison of mean intensities emitted at 570 nm from the
UOx substrates [236]
43

from lack of optimum distribution of enzyme on the electrode surface. Visibly more
distinct fluorescence was observed with sharper intensity emission from the 1:2 polymer
UOx ratio (Figure 3.6a). These images also suggest the active sites of enzymatic UA
oxidation on the electrode surface from sites offering increased fluorescence. Fluorescence
intensity was seen to decrease as the ratio of enzyme and polymer increased (Figure 3.6e
and Figure 3.7) in the matrix. As compared to the entrapped sample, the physisorbed sensor
surface (Figure 3.6d) portrayed very low or no emission at 570 nm, indicating unstable
immobilization without the polymer.

Figure 3.7 Plot depicting comparison of fluorescence intensities emitted from different
UOx loaded substrates at 570 nm. The mean pixel intensities of 1:2, 1:4 and 1:6
polymer-UOx substrates were 1830.89, 742.64 and 440.96 (a.u.) respectively [236]
These characteristics can also be observed from Scanning Electron Microscopy
(SEM) images where morphology of distribution of the polymer UOx matrix on the
working electrode (Figure 3.8) was seen. Topography of the physisorbed surface showed
enzyme distribution with amorphous morphology on the electrode surface as seen in Figure
3.8a. The enzyme entrapped in the cationic polymer (Figure 3.8b) showed a more
homogenous and smooth conformation, covered by the polymer coating. These imaging
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analyses provided visual evidence of surface functionalization for the immobilization
matrix.

Figure 3.8 SEM micrographs of UOx (a) physisorbed and (b) entrapped functionalized
substrates at 100 nm [236]
Electrochemical impedance studies (EIS) were carried out at 0.3 V from 1 mHz to
100 kHz in presence of the redox shuttle FCA to observe its influence on the resistive and
capacitive effects of different enzyme loading in the functionalization matrices. UOx
functionalized electrodes were tested using FCA redox probe (20 mM). The Nyquist plot
(Figure 3.9a) shows enhanced charge transfer resistance, Rct (semicircle area) for lower
polymer-enzyme ratio compared to the higher ratios (20.47 MΩ to 0.20 MΩ) with error
deviation within (+/-) 5.5%. This increase in electron transfer resistance can be attributed
to higher ratios of UOx in the matrix. As the thickness of the enzyme layer on the working
electrode increased, less active sites are available on the electrode for the FCA redox
reaction and electron transfer is decelerated.
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Figure 3.9 (a) Nyquist plot showing variation of impedance in presence of FCA at 0.3
V between 1 mHz to 100 kHz on functionalized substrates with varied loading; (b) Plot
depicting change in UOx activity and current density with varied UOx loading [236]

The semicircle portion, observed at high frequencies correspond to electron-transfer
limited process, with transfer of electrons between FCA and the electrode surface. A
second inflection depicted in the plot, can be accredited to the presence of multiple
capacitive effects as illustrated in Figure 3.9a. The straight-line portion represents diffusion
limited ion transfer process at low frequencies.[182] Rct is noted to increase with increased
thickness of polymer-enzyme matrix on the electrode. Negligible variation in solution
resistance (Rs) was noted among them. Impedance patterns were noted to change until 2.5
MΩ at lower frequencies; while at higher frequencies, beyond 2500 kHz, with increased
thickness of the film on the electrode, the change becomes less significant. The Bode plot
(Figure 3.10) obtained from these impedance studies shows increase in phase angle with
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Figure 3.10 Bode plot showing variation in impedance (a) phase angle and (b)
magnitude on different UOx loaded substrates with frequency from 0.001 Hz to 100
kHz at 0.3 V [236]
increase in frequency. Negative phase angle denoted a lag in response, confirming
formation of double layer capacitance. Electrode polarization impedance of the layer
formed on the electrode is noted from the slope of the magnitude of double layer
capacitance, Cdl at lower frequencies. Cdl formation conforms with conjugation and binding
of the UOx to the electrode surface, with accumulation of charge in the double layer.[183]
With increased loading of UOx, this capacitive behavior indicates insulating properties on
the surface, limiting charge transfer processes. Entrapped enzymatic electrodes have lower
Rct values than the physisorbed due to the ionic interactions between the polymer and UOx
as discussed before. With increased polymer-enzyme ratio, the potential agitation also
increased Cdl. Simulation and fitting of the data was performed using EIS Spectrum
Analyser software. The Nyquist data obtained from EIS was fitted to an equivalent circuit
(inset of Figure 3.9a) to determine the Rct and Cdl at the UOx – FCA interface of the
electrodes. The basic Randles circuit was modified by a secondary capacitive element,
adapted by a constant phase element (CPE). Due to coulombic interactions and constant
motion of FCA molecules towards and away from the electrode, constant diffusion of
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electrons occurs. The diffusion layer, modelled as a CPE, includes capacitive effects at 0.3
V, in parallel with Cdl and Rct.
Surface enzyme activity was studied for each electrode (various polymer-enzyme
ratios and physisorbed) to obtain a correlation between the electrochemical behavior of the
electrodes and surface activity. For electrochemical studies, the modified electrodes were
tested in UA solution (48 µM) and the responses were plotted against polymer-enzyme
ratios. The enzyme present on the modified electrode surface was quantified by carefully
scraping and dissolving the content from the modified electrode surface in a buffer solution
and running its absorbance studies at 570 nm. This enzymatic assay was used to calculate
the specific activity of UOx on the electrode surface. Compared to physisorbed UOx, the
1:2 ratio polymer entrapped UOx showed 76 % increased activity (Figure 3.9b). However,
with further increased ratio of enzyme on the surface, lower activity was noted, with more
enzyme retained on the electrode surface using 1:2 ratio. Retaining capability of the
enzyme reduced by 60 %, ascribed to greater leaching, in higher ratio of functionalization
matrix. Electrochemical studies performed from the varied functionalized substrates
exhibited higher current density of ~3.42 mA cm-2 for 1:2 matrix ratio. After
immobilization, drying and washing, 92% enzyme was observed to be retained on the
electrode surface in 1:2 ratio (0.23 U mg-1), with more leaching occurring in higher ratios
of the functionalization matrix. With vigorous washing of the electrode to remove excess
un-entrapped enzyme, increased ratio of enzyme on the electrode surface provided reduced
current density, which is consistent with the specific activity results and other
characterizations. All these entrapped UOx characterization studies optimized the
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immobilization ratio and suggested evidence for increased presence of active enzyme on
the electrode surface using 1:2 matrix ratio.
3.7 Reaction mechanism in enzymatic Uric Acid detection
The reaction mechanism of enzymatic UA oxidation is illustrated in Figure 3.11,
represented by yellow and green arrows. The enzyme UOx converts UA to 5hydroxyisourate through oxidation (Eq. 2). The formed 5-hydroxyisourate further reacts
with water to produce carbon dioxide and allantoin (C4H6N4O3) (Eq. 3). Yield of the
byproduct, H2O2 from this reaction was utilized in well-established colorimetric assay
techniques to quantify UA.[88, 184]
5 − ℎ𝑦𝑦𝑦𝑦𝑦𝑦𝑦𝑦𝑦𝑦𝑦𝑦𝑦𝑦𝑦𝑦𝑦𝑦𝑦𝑦𝑦𝑦𝑦𝑦𝑦𝑦𝑦𝑦 + 𝐻𝐻2 𝑂𝑂 → 𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴 + 𝐶𝐶𝑂𝑂2

….. (3)

To monitor the above reaction on the electrode surface, mediated electron transfer
(MET) can be applied with the incorporation of a redox electron shuttle. FCA is a redox
shuttle known to promote accelerated electron transfer. In widely used oxidase enzymes,
FCA receives electrons from the enzyme’s co-factor leading to MET, where electron
transfer to FCA (E0= -0.4 V) is more favorable.[185-188] In this approach, FCA was used

Figure 3.11 Schematic representation of uric acid oxidation by UOx and oxidation of
H2O2 via mediated electron transfer using FCA as redox shuttle [236]
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as an electron transfer mediator to quantify UA oxidation on UOx electrode, as shown in
Figure 3.11 and Eq. 4 and 5. The reduced Fe2+ (metal ion in FCA) undergoes a facile oneelectron oxidation on the electrode to the ferricinium state.[189]
𝑈𝑈𝑈𝑈𝑈𝑈𝑈𝑈 𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴 + 𝐹𝐹𝐹𝐹 3+ → 5 − ℎ𝑦𝑦𝑦𝑦𝑦𝑦𝑦𝑦𝑦𝑦𝑦𝑦𝑦𝑦𝑦𝑦𝑦𝑦𝑦𝑦𝑦𝑦𝑦𝑦𝑦𝑦𝑦𝑦 + 𝐹𝐹𝐹𝐹 2+
𝐹𝐹𝐹𝐹 2+ → 𝐹𝐹𝐹𝐹 3+ + 𝑒𝑒 −

….. (4)
….. (5)

However, UOx does not have any prosthetic group or cofactor; and the E0 of UA
(E0=0.59 V)[190] being 0.99 V higher than FCA, electron transfer from the active site of
the UA reaction to FCA is thermodynamically not feasible (Eq. 4). Instead, the electron
transfer is more favorable toward the native two electron O2 (E0=0.81 V) reduction reaction
forming H2O2 (Eq. 2). To understand the interactions between enzymatic oxidation of UA
and FCA, four different experiments were conducted as illustrated in Figure 3.12: (i)
behavior of FCA redox couple, (ii) inhibition of O2 in the enzymatic reaction, (iii)
inhibition of H2O2, and (iv) H2O2 assay studies, to monitor FCA interaction.
(i) Behavior of FCA redox couple: The predominance of Fe2+ ions in the natural state of
FCA can be seen in Figure 3.12(a) in the first cycle, where the Ipa (Fe2+→ Fe3+) is 1.6 times
higher than the second cycle (Fe3+→ Fe2+) (Eq. 6). However, as seen in the subsequent

cycle, the redox ions attained equilibrium (Ipa=Ipc). Hence, both ions are prevalent at the
electrode surface.
𝐹𝐹𝐹𝐹 2+ − 𝑒𝑒 − ⇌ 𝐹𝐹𝐹𝐹 3+ + 𝑒𝑒 −
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….. (6)

(ii) Inhibition of O2 in the enzymatic reaction: To understand the role of O2 in electron
transfer, our electrode system has been investigated by testing in presence and absence of
saturated O2. Results show a significant decrease in Ipa in the absence of O2 (Figure
3.12(b)). This decrease can be attributed to nil or limited production of H2O2. In the absence
of H2O2, no electron has been transferred from the active site of the enzyme to the electrode
through FCA. This also shows that FCA cannot receive electrons directly from enzymatic
UA oxidation (active site). In the absence of O2, some response has been observed due to
difficulties in eliminating O2 completely from the saturated solution.

Figure 3.12 (a) CV response of UOx entrapped electrode in presence of 20 mM FCA,
showing Cycles 1 and 2 with oxidation peak potential, Epa = 0.4 V, (b) Reaction
mechanism depicting inhibition of O2 in its absence and presence; and its effect on FCA
signal (Epa=0.45 V), (c) Electron transfer mechanism depicting inhibition of 1 mM
H2O2 in the absence and presence of HRP; and its effect on FCA signal, (d)
Concentration of H2O2 in presence and absence FCA, measured by H2O2 assay. All the
above CV measurements were carried out at 20 mV s-1 [236]
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(iii) Inhibition of H2O2: The importance of H2O2 in the electron transfer mechanism has
been investigated by consuming the formed H2O2 with the use of HRP and blocking its
reaction with FCA. Results from Figure 3.12(c) show a decrease in Ipa in the presence of
HRP as compared to its absence. This also shows that electron transfer occurs through its
by-product H2O2 to FCA and the electrode surface, the possibility of which has also been
reported previously.[168-169, 171] The interaction between the formed H2O2 and FCA is
seen in Figure 3.13, where there is a decrease in Epa by 150 mV and an increase in Ipa by
60% (at Epa 0.38 V) in presence of both FCA as well as H2O2. This indicates that H2O2

Figure 3.13 CV response of UOx entrapped electrode in presence and absence of 20
mM FCA to 0, 0.3, 1, and 50 mM H2O2 at a scan rate of 20 mV s-1. This reveals that
FCA acts as an electrochemical mediator for H2O2 oxidation [236]

(E0= -0.68 V) acts as a reducing agent in the reaction, with plausible electron transfer to
FCA (E0= -0.4 V). On the same electrode (Figure 3.13), in the absence of FCA there was
no defined electrochemical peak, showing no H2O2 oxidation in the same potential
window.
(iv) H2O2 assay studies: Sampling of electrolyte solutions from the above reactions was
performed to show that H2O2 was consumed during FCA redox reaction (Figure 3.12(d)).
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These results show that in the presence of FCA, there is a 6.5% decrease in H2O2
concentration, while in the absence of FCA, the H2O2 concentration remained unchanged.
All the above results support that electron transfer from H2O2 to FCA (Eq. 7) is
thermodynamically more favorable than the UA reaction at the active site to FCA (Eq. 4).
𝐹𝐹𝐹𝐹 3+ + 𝐻𝐻2 𝑂𝑂2 → 𝐹𝐹𝐹𝐹 2+ + 𝑂𝑂2 + 2𝐻𝐻 + + 2𝑒𝑒 −

….. (7)

3.8 Electrochemical characterization of entrapped enzymatic biosensor
For FCA oxidation on a bare electrode at a pH of 7.8, an Epa of 0.4 V and an Ipa of
2.6 mA were respectively noted with a peak separation, ΔE = 30 mV (Figure 3.14a). The

formal potential, Epa and ΔE of the other two electrodes (entrapped and physisorbed) were
seen to remain unchanged. In presence of UA, increased current density by 35 mA cm-2

was observed from the enzyme entrapped electrode, as compared to the other three. The
entrapped active surface coverage for the electrode (𝛤𝛤) was obtained as 5.57 x 10-14 mol-1
cm2 from the below equation, Eq. 8.
𝛤𝛤 = 𝑄𝑄/𝑛𝑛𝑛𝑛𝑛𝑛

….. (8)

where; F is the faradaic constant, Q is the quantity of charge consumed with an electron
transfer of n over a physical area, A. Compared to the other two electrodes, the enzyme
entrapped electrode has a characteristic steady state response in the scan beyond 0.4 V.
This increase can be attributed to improved diffusion of the analyte to the electrode’s
working area through the polymer-enzyme hybrid matrix. The double fold increase in
current density of the entrapped electrode compared to physisorbed shows that there was
an increase in enzyme ratio within the polymer matrix.[191] It is seen from Figure 3.14a
that, response of the sensor in the absence of FCA, provided much lower signal as
compared to, in the presence of FCA. This shows that FCA acts as a mediator in the
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reaction, enabling detection at an Epa lower by 200 mV. In the absence of UOx, the
biosensor showed reduced response by 26.811 %. A bare electrode in presence of the same
concentration of UA showed lower signal by 18.11 %. The biosensor was evaluated by
testing it with consecutive UA concentrations (0, 12–100 µM) in the physiologically
relevant ranges of sweat and wound fluid. In presence of FCA, results of the entrapped
biosensor showed a linear increase in Ipa having ordinate at 3.44 µA, with a linear
regression of y= 0.0111x+3.5251; R2=0.94523 and a standard deviation of 0.04 µA with
respect to the physiological UA concentrations (Figure 3.14a inset).

Figure 3.14 (a) CV response of 48 µM uric acid on bare, only polymer, UOx physisorbed
and entrapped electrodes in presence and absence of 20 mM FCA at the scan rate of 20
mV s-1. The inset is the plot of Ipa vs. uric acid concentration in physiological range
(12–100 µM). (b) DPV response of 48 µM uric acid on UOx physisorbed and entrapped
electrodes at the amplitude 50 mV in presence of 20 mM FCA. In the inset, the
continuous line represents entrapped electrode and the dotted line represents
physisorbed. [236]

These studies were repeated using the DPV technique as well (Figure 3.14b). Like
CV, the Epa in DPV is 0.33 V. The obtained current density in DPV was 52.3 % higher
than in CV, due to its ability to discriminate against charging (capacitance) currents
through pulses, and its sensitivity in yielding peaks to faradaic currents.[191] The UOx
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entrapped electrode provided higher current density compared to a UOx physisorbed
electrode as seen from Figure 3.14b. Linear calibration (Figure 3.14b inset) showed that
the UOx physisorbed electrode cannot be used for UA detection due to its ultra-low
sensitivity value of 100 nA µM-1 mm-2. Sensitivity of the entrapped electrode was 0.155
µA µM-1 cm-2 with an ordinate of 5.01 µA from a linear regression of y=0.01090x+4.9125;
R2=0.73106 and standard deviation of 79.43 nA. The UOx entrapped electrode showed
superior response, with enzyme activity retained through robust immobilization of the
enzyme in its working area, while the physisorbed sensor offered non-linear response with
a standard deviation of 32.92 nA on the same scale. With the entrapment technique also
providing improved

mechanical stability and minimized leaching within its

microenvironment, all analyses were performed with enzyme functionalized electrodes,
entrapped in the polymeric matrix.
Immobilization of an enzyme affects its catalytic activity. The enzymatic reactions
involving a single or multi-substrate with only one varying substrate follow MichaelisMenten kinetics in Eq.9, derived from the Lineweaver-Burk equation,

1

𝐼𝐼𝑠𝑠𝑠𝑠

=

𝐾𝐾𝑚𝑚(𝑎𝑎𝑎𝑎𝑎𝑎)
𝐼𝐼𝑚𝑚𝑚𝑚𝑚𝑚
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..... (9)

where, Km(app) is the Michaelis-Menten constant of applied enzyme on the electrode surface,
Iss is the steady state current measured at diffusion-controlled region, Imax is the maximum
current obtained, and c is the bulk concentration of analyte (48 x 10-9 mol cm-3). [192-193]
The effective Michaelis-Menten constant for functionalized UOx was determined by
electrochemically measuring the diffusion limited current resulting from FCA oxidation
(ΔIpa). ΔIpa represents the difference in Ipa between the presence and absence of UA.

Assuming the same loading of UOx on both electrodes, the Km(app) calculated was 1.13 x
10-8 M. Response of the entrapped electrode in presence and absence of UA is shown in
Figure 3.15.

Figure 3.15 CV response of UOx entrapped electrode in presence and absence of UA at
a scan rate of 20 mV s-1 [236]
3.9 Continuous monitoring and stability at physiologically relevant temperatures
Studies to determine stability of performance during continuous monitoring of UA,
were performed over 30 min, in presence of the same concentration of UA (48 µM) (Figure
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3.16a). Results showed a gradual decrease in response after 12 min. After 20 min., the
prepared biosensor still maintained 80% of the signal. With each continuous measurement
up to 12 min, this biosensor recorded stable response within 10% variation over 3 days

(b)

Figure 3.16 (a) Plot representing continuous measurements of the UOx electrode over
30 min in 48 mM uric acid. (b) Plot representing shelf life of the UOx electrodes, where
the measurements were carried out in 48 mM uric acid [211, 236]

(Figure 3.16a). Stability studies performed over a week in buffer solution containing UA
showed that the entrapped sensor offered stable signal over multiple days with repeated
use (Figure 3.17a). The physisorbed electrode, however, showed reduced performance by
60% after day 1.
The enzymatic biosensor was assessed under physiologically relevant variations of
temperature to analyze its performance and feasibility for detection from a wound milieu.
Measurements were conducted at elevated body temperatures of 400C considering a rise in
normal physiological temperature by about 2-30C.[72] Stable performance was observed
over a week (Figure 3.17c) in the buffer solution with UA. With each continuous
measurement up to 12 min, the biosensor recorded stable response within ∼ 10% variation
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over 3 days (Figure 3.17c). This shows that the entrapped enzymatic biosensor provides
stable measurements of UA at physiologically relevant variations of body temperature.

Figure 3.17 (a) Plot representing repeatability of the UOx electrode obtained through
repeated measurements of 48 µM uric acid over a week; (b) Distribution curve
representing reproducibility obtained from nine different UOx electrodes measured at
the same condition [211, 236]
Reproducibility studies were also performed using multiple electrodes. The
behavior of these electrodes in the same concentration of UA were plotted to obtain a
normal distribution curve (Figure 3.17b). Reproducible results were obtained for a
frequency of 5, providing consistent current of 6 µA. The distribution data provided a
standard deviation of 𝜎𝜎=0.5 µA for n=9, obtained from Eq. 10.
𝜎𝜎 = √𝑋𝑋

….. (10)

where, X is the variance of the current response obtained from the different electrodes. It
can be inferred that the obtained standard deviation value provides reasonable response for
detection, as can also be seen from the figure (Figure 3.17b). Studies to determine the
storage and shelf life of the sensor were performed over a week in buffer solution
containing UA. Shelf lives of the enzyme entrapped electrodes were studied in the same
concentration of UA over a week’s duration. In this experiment, measurements were taken
over multiple days and the electrodes were stored at -4 0C when not in use. Results (Figure
3.16b) showed that the electrodes had a shelf life of more than 2 days, after which there
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was a ~ 20% decrease in current. The biosensor displayed stable response for continuous
measurements with repeated use.
3.10

Selectivity from major electroactive interferents
Common electro-active interferents of UA are dopamine (DOP) and ascorbic acid

(AA). These analytes are known to have oxidation potentials close to that of UA and
demonstrate similar electrochemical behavior. [194] This leads to the close overlapping of
response with their oxidation peaks, which are obtained at similar potentials. Healthy
human sweat is known to contain ~ 10 µM (0.18 mg. per 100 cc.) ascorbic acid (AA).[195]
Present in abundance and in much higher concentration in extracellular fluid (46–97
µM)[196], it is a key interferent in detection. Known for its biological role as an
antioxidant, AA promotes healing through its role in collagen synthesis.[194] Dopamine
(DOP), an important neurotransmitter which plays a role in cutaneous wound and dermal
tissue healing [197], is also known as an electroactive interferent in UA detection.

Figure 3.18 (a) Amperometric signal of UA (100 µM) in the absence and presence of
ascorbic acid (100 µM) and dopamine (100 µM). (b) Chart representing the reduction
in current in presence and absence of ascorbic acid and dopamine at 20 s [236]
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Amperometric studies have shown (Figure 3.18a) that the biosensor offers response
from UA within 5 s. It is observed that in presence of AA, the baseline remains stable and
unchanged over 5 s. However, in presence of DOP, there is a shift in the baseline by 0.2
µA, after which the signal is noted to stabilize at 10 s. It can also be seen that despite
interference in presence of AA and DOP at higher physiological concentrations (100 µM),
the maximum decrease in current was only 82 nA and 57 nA (20 s) in presence of DOP
(Figure 3.18b). This shows that our biosensor can record reasonable measurements within
the physiological range.
3.11

Conclusion

Conventional real-time biosensors in wound care are yet to provide direct longitudinal
measurements from a wound milieu which can provide a comprehensive understanding of
tissue recovery. Although electrochemical investigations have been explored for woundcare, they are mostly non-enzymatic. In this work, an enzymatic biosensor has been
designed for continuous, non-invasive detection of wound biomarker, UA. Different
characterization techniques were employed to understand the immobilization of UOx
within cationic polymer, PVA-SbQ. This unique approach displays superior response as
compared to physisorption on a solid support. An optimum ratio of polymer : enzyme was
identified to entrap the enzyme; and stable response was obtained with repeated use. Use
of FCA as a redox probe provided minimum interference and enhanced response over a
wide physiological range through efficient electron transfer between the enzyme and the
substrate. This approach has the potential to offer direct measurements from UA, as a
biomarker for wound chronicity.
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CHAPTER 4
NANOCOMPOSITE ENZYMATIC SENSOR FOR MONITORING XANTHINE IN WOUND
DIAGNOSTICS
In this study, an enzymatic biosensor employing enzyme XO to monitor Xanthine for
potential wound healing assessment has been reported. Mediator free detection, eliminating
the use of an external electron shuttle, was investigated through the incorporation of HRP
and a specific nanocomposite of multi-walled carbon nanotubes (MWCNT) and gold
nanoparticles (AuNP). The role of a nanocomposite of MWCNT/AuNP was explored in
enzymatic electrochemical detection of Xanthine for accelerated electron transfer.
Inclusion of this nanocomposite was explored to obtain enhanced sensitivity. Sensing
response using CV was recorded within a broad physiological range between 0.1 nM and
7.3 mM.
4.1 Enzymatic detection of Xanthine
Monitoring the biochemical activity of pertaining analytes aids in leveraging
biochemical detection of wound severity. Xanthine is known as an inflammatory biomarker
[61] capable of forming reactive oxygen species (ROS) such as hydrogen peroxide (H2O2),
which promotes healing. Such species act as scavengers of oxygen radicals to facilitate
tissue recovery. [198] In the event of cell rupture, Xanthine is formed in the wound
(localized xanthine) from the breakdown of released energy of metabolites in the tissue.
Through the utilization of existing cellular biochemical pathways, this work illustrates the
viability of a biocompatible electrochemical approach for potential assessment of lesion
severity from quantifiable measurements of associated biomarkers. Here, an
electrochemical sensor for detection of Xanthine employing enzyme, XO has been
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presented. To facilitate increased reduction of H2O2 on the electrode, enzyme HRP was
introduced in the study. Enzymatic performance of the biosensor was assessed
electrochemically, and its sensing performance was recorded to obtain an understanding of
the electron transfer between the analyte and the transducer.
4.2 Effect of physiological pH on detection
Since physiological events are pH-dependent, pH plays a role in the process of lesion
healing, influencing the biochemical reactions involved in healing. As wounds are known
to shift from a higher to a lower pH with healing, a correlation could potentially enable
calibration of the enzymatic biosensor as a tool for wound monitoring.
Enzyme XO is known to be active at a slightly alkaline pH (7.5-7.8), with a pKa value
of 6.5 and an isoelectric point around pH 6[199-200], while HRP is known to provide
optimum response around pH (6-6.5) having a pKa and isoelectric point of 6.4 and 7.2,
respectively.[201-202] To understand the activity of XO/HRP in the mixture and assess
electrochemical performance, the bi-enzymatic sensor was analyzed over a pH range from
5.5 to 9.5. Higher response was obtained between pH 7 and 8 (Figure 4.1), with increased

Figure 4.1 Effect of pH on the current and potential of the bi-enzymatic sensor in
presence of xanthine functionalization in presence of Xanthine [244]
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current at pH 7.5 at a lower Epc. There was a shift in the peak potential with reduced values
as the pH changed from acidic to alkaline.
These investigations offer an improved understanding of the pH environments suitable
for enzymatic detection of Xanthine. This shows that the bi-enzymatic sensor can provide
responses in physiologically relevant pH ranges for wound assessment.
4.3 Use of nanomaterial in electrochemical detection
Nanotechnology and different multi-dimensional materials are being extensively
explored for the purpose of designing smart, wearable medicinal platforms. Such materials
include those of carbon, silver and gold. [76, 203-205] Inclusion of such nanomaterial
provides larger electroactive area and higher surface-volume ratios across the electrode
surface. Use of suitable material offers increased conductivity across the active area,
promoting accelerated electron transfer through increased binding sites and surface
interactions. These materials provide augmented response with good electrochemical
stability in detection.
4.3.1

MWCNT/AuNP nanocomposite in detection of Xanthine

Nanomaterials of carbon and gold notably provide superior performance owing to
greater conductivity and catalytic activity.[137, 206-207] Some of their advantages include
increased electrode surface area, fast electron transfer, and improved surface confined
reactions. Carbon nanotubes (CNT) have open-end structures with edged planes of highly
ordered pyrolytic graphite.[208-210] The walls of multi-walled carbon nanotubes
(MWCNT) with large basal planes is highly conductive while their edges hold high
capacitive and electrocatalytic properties.[210] Studies have shown that its large number
of edged planes[208] can enhance molecular redox activity by multiple orders of
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magnitude.[210] Use of AuNP not only improves conductivity but also provides good
electrochemical stability in detection. It offers the biosensor with a suitable
microenvironment and a biocompatible edge to target wearable healthcare innovation. A
combination of MWCNT and AuNP suggests significant improvement in electrochemical
detection of Xanthine, to attain enhanced sensitivity and superior response.
4.4 Experimental
4.4.1

Materials
XO lyophilized powder containing 7 U mg-1 was purchased from Sigma Aldrich

and used for Xanthine oxidation. XO enzyme immobilization was performed on SPCE
purchased from CH Instruments, Inc., United States. 0.2 U ml-1 HRP of analytical grade
was used from ThermoFisher Scientific. MWCNT (o.d. = 10-20 nm, i.d. = 2-10 nm and
length = 0.5–200 µm), 20 nm AuNP (0.5 µM), and dimethylformamide (DMF) were
purchased from Sigma Aldrich. Xanthine, sodium hydroxide (NaOH), H2O2, sodium
phosphate monobasic (NaH2PO4) and sodium phosphate dibasic (Na2HPO4) were used of
analytical grade. All aqueous solutions were prepared using deionized (DI) water. PBS (pH
7.8) (20 mM) was prepared using NaH2PO4 and Na2HPO4 salts and used in electrolyte
solutions.
4.4.2

Apparatus and Methods
The working electrodes were modified with 20 µg cm-2 MWCNT prepared in DMF

by drop-casting and drying at 60ºC, followed by 0.5 µM AuNP (1:1 V/V) and subsequent
drying at 60ºC. Electrode surface characterizations were performed using scanning electron
microscopy (SEM JEOL 6330) and transmission electron microscopy (TEM Philips
CM200) to understand the surface morphology of the nanocomposite electrodes. Atomic
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force microscopy (AFM) was utilized to obtain an idea of the surface roughness of these
functionalized electrodes. Electrochemical impedance studies (EIS) were performed using
Metrohm Autolab analyzer to assess the surface impedance characteristics and understand
its effect on sensing performance.
The ratio of MWCNT:AuNP functionalization was optimized with 1:1, 1:2, 2:1,
1:3 and 3:1 V/V. The nano-material functionalized electrodes were further modified with
enzyme catalysts 0.2 U ml-1 XO and 0.2 U ml-1 HRP. Mixtures of XO and HRP at different
molar ratios in PBS (1:1, 1:2, 2:1, 1:3, 3:1) were explored to immobilize the enzymes onto
the MWCNT/AuNP modified electrodes. The amounts of XO and HRP (0.2-0.6 U ml-1)
were optimized to obtain improved electron transfer.
All enzyme immobilizations were achieved through drop casting, nitrogen drying,
and rinsing in PBS to remove un-entrapped enzymes prior to testing. Drying in nitrogen
allowed for the removal of excess water from the electrode surface, forming a gel like
structure.[211] All steps involving the enzymes were carried out in an ice-box to reduce
denaturation. CV was performed using the analytical system model CHI-230B potentiostat
from CH Instruments, Inc. Standard electrochemical characterizations were carried out in
a classical three-electrode system consisting of screen printed carbon electrodes (SPCE),
an external Ag/AgCl as reference electrode, and a Pt counter electrode. This three-electrode
system was tested in an electrochemical cell setup with a 3 mL electrolyte solution to assess
the performance of the nanomaterial-enzyme functionalized electrode in different
concentrations of Xanthine at a pH of 7.8. These measurements were performed at 20 mV
s-1 to record the generated H2O2 at the cathode between -0.1 V and -0.6 V.
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Control studies were performed in the absence and presence of different
nanomaterials (MWCNT and AuNP) with the working electrode being infused with the
enzymes XO and HRP. The electrodes tested were (i) bare, (ii) XO, (iii) AuNP/XO, (iv)
MWCNT/XO, (v) MWCNT/Au/XO, (vi) XO/HRP, (vii) AuNP/XO/HRP, (viii)
MWCNT/XO/HRP, (ix) MWCNT/AuNP/XO/HRP and (x) MWCNT/AuNP/HRP.
4.4.3

Electrode functionalization

It was seen that higher current response was obtained from 1:1 as compared to other
ratios (Figure 4.2), owing to uniform distribution of MWCNT:AuNP across the electrode
surface. Lower response from increased amounts of AuNP across the MWCNT decorated
surface can be attributed to reduced electrode surface area, from coverage of the pores on
the carbon substrate.[212] Higher amounts of MWCNT were noted to provide increased
capacitance with a small difference in faradaic current.[213] This showed that 1:1 ratio of
MWCNT/AuNP offered optimum catalytic response.

Figure 4.2 Plot depicting change in response with varied MWCNT/AuNP and XO/HRP
functionalization in presence of Xanthine [244]
From the different molar ratios of XO:HRP, it was seen that 1:1 ratio (0.2 U ml-1
XO:HRP) provided higher signal as compared to the other bi-enzymatic electrodes (Figure
4.2). Reduced current response in higher enzyme ratios can be ascribed to either lower
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production of H2O2 from decreased amounts of XO, or due to reduced electron transfer
from lesser amounts of HRP.[214] This shows that 1:1 ratio of XO:HRP provided optimum
measurements.
4.5 MWCNT/AuNP nanocomposite sensor surface characterization
SEM Imaging Analysis was utilized to study the surface topography of nanostructure
modified electrodes. These studies showed that the MWCNT were randomly distributed
across the electrode surface forming a mesh like structure (Figure 4.3a). Such a network of
nanostructures allow for improved immobilization of the enzyme with reduced leaching.
Deposition of AuNP on these MWCNT decorated electrodes showed a more homogeneous
conformation at 200 nm with the appearance of small globules (Figure 4.3b), spreading
across the electrode surface. This comparatively uniform coating of AuNP on the working
electrode will offer larger surface-volume ratios to improve the conductivity of the
biosensor and increase current signal. [215]

Figure 4.3 SEM images of (a) MWCNT, (b) MWCNT/AuNP decorated electrode [244]

TEM Imaging Analysis showed the network distribution of MWCNT across the sensor
surface (Figure 4.4a). Diameter of structures distributed in the MWCNT matrix is about 12
nm, as observed from the high resolution TEM image at 20 nm (inset: Figure 4.4a). This
assisted in providing higher electrochemical stability from increased conductivity of its
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(b)

(a)

(c)
22.1 nm

12.96 nm

Figure 4.4 TEM images of (a) MWCNT, (b) MWCNT/AuNP and (c)
MWCNT/AuNP/XO decorated electrodes
edged planes and higher electroactive area. Incorporation of 20-22 nm AuNP on the
MWCNT decorated surface (inset: Figure 4.4b) offered to further increase the electroactive
area with increased conductivity, to promote electron transfer between the transducer and
the analyte. Surface interactions were suggested by the deposited AuNP across the
MWCNT functionalized surface (Figure 4.4b). Spatial distribution of the AuNP displayed
visible agglomeration across specific sites of the MWCNT framework, depicting increased
sites for binding. This can augment electron transfer with improved electrocatalytic
properties. Incorporation of enzyme onto the nanocomposite functionalized sensor,
illustrated its homogeneous integration with the nanocomposite surface, by the formation
of a relatively uniform layer across it (Figure 4.4 c). The enzyme was seen to form a coating
over areas of the nanocomposite surface. As seen, this enzyme blanket was noted to conceal
the underlying MWCNT mesh in the region. This can be ascribed to increased interactions
of the enzyme with the functionalized sensor surface, arising from accredited increase in
binding sites offered by the nanocomposite.
AFM imaging analysis provided an understanding of the average surface roughness of the
nanocomposite functionalized sensor surface at atomic resolution. At a depth of about 165
nm, the appearance of MWCNT was noted (Figure 4.5a), with the presence of globule
clusters denoting the presence of AuNP. Visible agglomeration of AuNP is distinct at a
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(a)

(b)

Figure 4.5 AFM images of MWCNT/AuNP nanocomposite electrodes at different
depths of (a) 164.5 nm, (b) 173 nm and (c) 1.6 µm
depth of 173 nm (Figure 4.5b). This suggests obvious interactions between the MWCNT
and AuNP distributed across the sensor surface. Surface topography of the nanocomposite
at a height of 1.6 µm was observed (Figure 4.5c). This nanocomposite surface provided an
average surface roughness (ASR) of approximately 0.12 µm.
EIS characterization of the nanocomposite sensor was conducted between 1 mHz and 100
kHz at a potential of 5 mV in buffer to explore the electron transfer properties. Compared
to the bare electrode, a reduction in Rct was observed from the MWCNT/AuNP

Figure 4.6 Nyquist plot showing variation of impedance on electrodes functionalized
with MWCNT and MWCNT/AuNP at 5 mV between 1 mHz and 100 kHz in presence
of buffer
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nanocomposite electrode as observed from the Nyquist plot (Figure 4.6). Decrease in
electron transfer resistance from 30940 kΩ to 168.55 kΩ can be accredited to increased
conductivity from the hybrid nanocomposite matrix. A decrease in Rct by 1512.45 kΩ was
observed with the integration of AuNP on the MWCNT functionalized surface. This
denoted increase in conductivity from increased interactions between the MWCNTs and
AuNPs, suggesting increased electron transfer properties.
4.6 Reaction mechanism employed in detection
Xanthine dehydrogenase is prevalent in normal tissue and transforms to XO in the
case of injury. XO is an oxidoreductase enzyme with a cofactor, FAD that facilitates its
oxidation to terminal purine product, UA. XO has 2 molecules of FAD bridged by a pair
of ferric mercaptide groups.[216] Purine substrates bound by the isoalloxazine ring system
of one FAD undergoes oxidation in presence of O2 and H2O (Eq. 1). The presence of a
molybdenum cofactor in XO allows for the transfer of electrons in the oxidation pathway
to convert to by-product H2O2. The oxidation pathway of Xanthine as illustrated in Figure
4.7, was utilized in the study, with the enzymes acting as catalysts to facilitate detection.

Figure 4.7 Schematic showing electron transfer mechanism in xanthine oxidation by
XO and HRP on a nanocomposite functionalized electrode [244]
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Enzymatic oxidation of Xanthine was quantified by measuring the formed H2O2 on the
electrode.
HRP, being a metalloenzyme, has an iron heme group and contains a histidine
residue, which is in a vacant resting site.[217] H2O2 can attach to this vacant site during its
reduction-oxidation reactions, where an oxygen atom can bind during activation. This
position is considered as the active site for enzyme binding.[217] It can be observed from
Eq. 11 that HRP catalyzes the reduction of H2O2 to water and oxygen.
𝐻𝐻𝐻𝐻𝐻𝐻𝐻𝐻𝐻𝐻𝐻𝐻𝐻𝐻𝐻𝐻𝐻𝐻𝐻𝐻ℎ 𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝 + 𝐻𝐻2 𝑂𝑂2 → 𝐻𝐻2 𝑂𝑂 + 𝑂𝑂2

….. (11)

Presence of HRP was noted to improve electron transport of H2O2 by enabling rapid
transfer of electrons between the enzyme and the transducer. This enabled increased
reduction of H2O2, in turn offering amplified signal output with improved quantification
for biomarker detection.[218-219]
The use of physiologically relevant enzymes allows them to act as natural catalysts
in detection. Utilizing such enzymes allows for improved electrocatalytic activity with
specific response to the target analyte.
4.7 Role of MWCNT/AuNP nanocomposite in Xanthine detection
Potentiometric analyses enabled assessment of electrochemical performance of the
nanomaterial-enzyme functionalized electrode in a broad range between 0.1 nM and 7.3
mM. Studies were conducted with different increasing concentrations of Xanthine prepared
in PBS at pH 7.5. These measurements were performed at 20 mV s-1 to record the generated
H2O2 at the cathode between -0.1 V and -0.6 V, with all potentials reported with respect to
Ag/AgCl reference electrode.
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In this process, the H2O2 byproduct reduction (Eq. 12) was monitored on the
MWCNT/AuNP/XO functionalized substrate, to measure the electrical signal generated
from the exchange of electrons between the electrode and the reduction reaction.
𝐻𝐻2 𝑂𝑂2 + 2𝐻𝐻 + + 2𝑒𝑒 − → 2𝐻𝐻2 𝑂𝑂

….. (12)

Reduction signal for the enzymatic nanocomposite sensor was noted to have a
lower onset voltage (0.2 V) with a higher slope compared to XO or only MWCNT, AuNP
or bare electrode (Figure 4.8a) revealing its enhanced electrocatalytic properties. In
presence of Xanthine, the nanocomposite has a peak at Epc -0.5V, however no definite
peak appeared for the other three electrodes. It can be seen from the same figure that a
MWCNT/XO functionalized electrode provided higher signal for Xanthine by 15 μA,
owing to greater electroactive area as compared to AuNP/XO modified electrode. A
combination of both the MWCNT and AuNP, however, was seen to provide significant
increase in response as compared to their use individually. At an Epc of -0.5 V, in the same
concentration of Xanthine, Ipc of 36.4 μA was observed from a MWCNT/AuNP/XO
(b)

(a)

Figure 4.8 (a) Comparison of CV signals of various XO electrodes in presence of
xanthine, (b) CV signals of various xanthine concentrations from MWCNT/AuNP/XO
biosensor. Inset: Linear regression plot of the biosensor [241]
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modified electrode. This nanocomposite electrode offered a 36-fold increase in response
as compared to other enzymatic electrodes.
The nanocomposite modified biosensor was evaluated by testing it with different
increasing concentrations of Xanthine between 0.1 nM and 7.3 mM. As depicted in Figure
4.8b, a linear increase in Ipc was observed from 11.2 μA to 36.5 μA, with increase in
concentration. This nanocomposite modified XO electrode offered a sensitivity of 18.57
nA μM-1 cm-2 with enzyme activity retained through irreversible immobilization of the
enzyme on its working area. The enzyme immobilization processes provided improved
performance by 25 μA with minimized leaching within its microenvironment, allowing
diffusion of the analyte towards the working area of the transducer surface.
4.8 Bi-enzymatic performance using MWCNT/AuNP nanocomposite
To enable enhanced electron transfer between the electrode and the analyte, HRP
enzyme was introduced in the system to investigate Xanthine detection. The presence of
HRP increased the current density by 71.42 µA cm-2 at an Epc=0.5 V in presence of
Xanthine. This electrode also displayed lower onset potential (0.2 V) compared to a single
enzymatic electrode. This indicates improved electrocatalytic activity. In comparison, a
bare electrode shows no definite peak due to no formed H2O2. The bi-enzymatic electrode
was thus seen to show an enhanced response to the same concentration of Xanthine.
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Electrochemical analyses showed that XO provided an onset potential of -0.3 V in
presence of Xanthine with no defined reduction peak (Figure 4.9a). This was due to
sluggish reduction in the XO functionalized substrate. The presence of isolated MWCNT
or Au nanomaterial on the bi-enzymatic electrode provided lower response in presence of
Xanthine (Figure 4.9b). A MWCNT functionalized enzymatic electrode provided a 2-fold
increase in signal as compared to AuNP modified electrode. The presence of a
nanocomposite from a combination of MWCNT and AuNP offered a further enhanced
response from the enzymatic electrode at a low onset potential of 0.3 V. An increase in
current signal by 7 μA was observed at an Epc= 0.5 V with a lower onset potential of 0.2
V.

Figure 4.9 (a) CV signals of bare, MWCNT/Au functionalized with XO or HRP or both
in presence of 32 μM xanthine, (b) CV signals of bare, XO/HRP electrodes with
MWCNT or Au or MWCNT/Au in presence of 32 μM xanthine; Insets: (c) Linear
regression plot of the bi-enzymatic sensor, (d) Linear regression plot of the sensor at
elevated concentrations [244]
Electrochemical response from the nanocomposite electrode was evaluated in the
presence of increasing concentrations of Xanthine in the physiologically relevant ranges
for wound monitoring. Typical concentrations of Xanthine are known to vary between 3
and 5 µM in healthy individuals with therapeutic levels rising from 35 to 160 µM.[63, 220]
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Sensor response employing the nanocomposite of MWCNT/AuNP was evaluated within 6
μM (inset: Figure 4.9c) and elevated concentrations (inset: Figure 4.9d). Sensor design
employing this nanocomposite assisted in providing a linear response between 22 μM and
0.4 mM (inset: Figure 4.9d), broader than the physiological range. With a detection limit
of 1.3 μM, enhanced performance was recorded (inset: Figure 4.9c). An increase in Ipc was
recorded when subjected to different increasing concentrations of Xanthine within the
physiologically relevant range. This nanocomposite modified bi-enzymatic electrode
offered a sensitivity of 155.71 nA μM-1 cm-2 through irreversible immobilization of the
enzyme on the working area. Improved response was obtained in the presence of increased
concentrations of Xanthine due to increased reduction of H2O2 on the nanocomposite
functionalized bi-enzymatic sensor.
The nanocomposite of MWCNT/AuNP offered larger electroactive area for
improved enzyme loading and enhanced sensitivity. This uniformly spread nanomaterial
composite provided greater electrocatalytic activity ratios.[221] This approach
incorporating enzymes, XO and HRP, in combination with the nanocomposite of
MWCNT/AuNP, allowed for improved quantification in Xanthine biomarker detection.[5,
222]
4.9 Interference studies
Wound exudate has high protein content, comprising several electrolytes and
inflammatory components.[223] Analogy of acute wound fluid has previously shown the
presence of different ions like sodium, potassium, chloride, urea and creatinine; besides
other cytokines, leucocytes, lysozymes, macrophages, neutrophils and other microorganisms. Thus, biochemical analysis of a wound environment using an electrochemical
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biosensor may be affected by interference from such electroactive species. Among the
wound fluid components, such species are hypoxanthine, uric acid, ascorbic acid and
dopamine. Xanthine is produced from hypoxanthine and leads to the formation of uric acid
in purine metabolism, using XO.
XO being the key catalyst in the biosensor, such purine metabolites are interferents in
detection. Like purine metabolites, the wide presence of electroactive species such as
ascorbic acid and dopamine in humans will also interfere with Xanthine detection. Under
physiological conditions, interference from hypoxanthine (8 µM) and uric acid (0.5 mM)
were thus investigated, in the same potential window. It can be seen from Table 4.1, that
change in response between 3.8 % and 9.9 % was observed with the presence of these
interferents. With the presence of ascorbic acid (34 µM), comparatively higher interference
was noted, with a change in response by 11.8 %, while dopamine (196 pM) was seen to
depict an interference of 8.8 %. Interferent concentrations were chosen as per the higher
biological levels, with detection in presence of lower physiological concentrations of
Xanthine. This shows that even in presence of higher concentrations of the common
electroactive interferents, the sensor signal for lowest concentration of Xanthine does not
deviate beyond (+/-) 6 %. Thus, this enzymatic biosensor can be utilized to determine
Xanthine in physiologically relevant biofluids.

Table 4.1. Response of sensor for 3 µM xanthine in absence and presence of interfering
biomolecules [244]
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4.10

Conclusion

A bi-enzymatic biosensor was developed using two enzymes, XO and HRP, for
detection of Xanthine within physiologically relevant ranges. Electrochemical analyses
from nanomaterial modified bi-enzymatic electrodes provided enhanced responses with an
increased reduction of by-product H2O2. Linear response was obtained with increasing
concentrations of Xanthine over the concerned range. Incorporation of specific
MWCNT/AuNP nano-composite in this study paves a path for improved detection of such
purine metabolites, with a potential for quantitative assessment of healing.
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CHAPTER 5
DESIGN OF BIOSENSOR FOR WEARABLE WOUND MONITORING AND CLINICAL SAMPLE
VALIDATION

In this chapter, specific properties of materials employed in sensor design have been
investigated. Hydrophilicity of the sensor surface was explored using Corona Plasma, to
obtain an understanding of increased loading and functionalization across the substrate.
Electrochemical performance of screen-printed-carbon based electrodes fabricated on
cotton gauze was evaluated in enzymatic UA detection for wearable wound monitoring.
For the first time, analyte measurements from clinical extracts of purulent samples were
recorded using optical and electrochemical techniques, to establish non-invasive detection
of UA and Xanthine in relevant biological fluids from around injured tissue.
5.1 Sensor surface hydrophilicity
Materials extensively explored in attaining enhanced electrochemical response include
nanomaterials of MWCNT and AuNP. Although they provide improved conductivity and
electrocatalytic performance with good electrochemical stability, these materials impart
increased hydrophobicity to the surface of the transducer, owing to the presence of nonpolar groups. [224-225] This restricts increased loading and functionalization across the
transducer surface, attenuating response from it. The use of Corona Plasma was
investigated in this study, to improve the hydrophilic properties of the functionalized sensor
surface. A hydrophilic surface, with the presence of polar groups, offers improved adhesion
and wettability to confine surface molecules onto the desired area for augmented response.
Corona Plasma is a low temperature surface treatment performed at atmospheric
pressure. It is a technique which enables polarization of a surface through activation of the
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surface chemistry of its particles. In this method, a high voltage is applied between the tip
of a sharp, pointed electrode which has the ability to ionize air in a limited space around it,
and a counter-electrode connected to ground. A schematic of this setup is shown in Figure
5.1a.

(a)

(b)

~V

Corona discharge
Drift region

Substrate

Figure 5.1 (a) Schematic displaying the working mechanism of Corona Plasma in air,
(b) Experimental setup of electrode treatment using Corona Plasma
Increased acceleration of electrons in the field generated near the tip, creates an electron
avalanche which increases ionization of the surrounding air molecules. At a point where
this non-uniform electric field in air becomes almost negligible at a certain distance from
the electrode, a potential gradient develops when a corona glow discharge is ignited. This
electric discharge causes increased ionization, creating dielectric breakage of air from
increased collision of atoms, electrons and ions. The produced corona energy breaks
molecular bonds of the surface to which it is directed, increasing the surface energy of the
substrate. Open molecular chains bond with free oxygen radicals forming additional polar
groups on the substrate surface, which have strong affinity to polar solvents. The formed
radicals react with the corona discharge in air to create polar functional groups and impart
them to the directed surface, thereby increasing its hydrophilicity and improving its
adhesion and wettability characteristics. Such treatment possesses the ability to selectively
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modify non-polar surfaces by modifying its surface tension. Once the energy of the surface
molecules exceeds the surface tension of the solvent molecules, adsorption/wettability
takes place when the adhesive forces between the substrate surface and the liquid exceed
the cohesive forces of surface tension between the liquid molecules on the surface.
Intensity of the electric field generated at the tip activates the surface energy of its
particles. Surface activation from electric discharge in limited air space improves adhesion
properties of the surface thereby enhancing its bonding properties, preventing detachment
of coatings from the surface. Improved adhesion of chemicals and polymers is obtained
from enhanced physical and dipolar interactions, through the introduction of reactive
groups and free radicals to the surface, in such treatment. This allows for increased loading
and functionalization to enable improved response.
When treating a carbon functionalized surface, the chemical interactions between
oxygen molecules in air and the substrate surface increases with the creation of strong
covalent bonds of greater polarity. With surface modifications from deposited polar
functional groups, increased surface tension results from increased energy of the surface
particles. While altering the surface chemistry of its particles, adsorption of reactive groups
occur on the surface, imparting changes to surface conductivity and electroactive area.
Increased conductivity results from the generated positive ions from increased ionization,
that are drawn to the negative ions on the substrate surface, in an effort to neutralize to
atoms.
5.2 Detection of wound biomarker from wearable construct
Wearable biosensing for wound management offers promise in miniaturized,
economical and convenient therapy through smart technology. As an attempt to transform
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wound care with wearable monitoring of healing, the design feasibility of a biosensor on a
flexible, healing construct has been evaluated in this study. The designed biosensor aims
toward personalized wound monitoring, complementing wearable wound management in
medical IoT. [211]
Design of an electrochemical biosensor was examined on a flexible, healing construct
of cotton gauze. A three-electrode sensing system was fabricated, comprising enzyme UOx
entrapped in PVA-SbQ on the working electrode, using Ag/AgCl as reference electrode. A
miniaturized, flexible, electronics platform with an ultra-low power potentiostat and
microcontroller were built and tested for wireless data transfer to assess the feasibility of
the enzymatic sensor for detection of biomarkers from extracts of biofluids in and around
an injury.
5.3 Non-invasive detection of wound biomarkers
To evaluate this biosensor for human subject analyses, we investigated detection of UA
and Xanthine in extracted samples of biofluid from sweat and wound milieu. When an
injury occurs, fluid oozes in and around a wound through diffusion in the sweat glands and
surrounding tissue in the dermal layers of skin with changes in osmotic gradients (Figure

Figure 5.2 Schematic displaying diffusion of analyte from sweat glands through
underlying dermal and epidermal layers of skin
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5.2). At the site of an injury, its vicinity also has a rise in analyte concentrations. With UA
concentrations between of 20 and 30 µM in sweat [226], measuring this analyte noninvasively from sweat in wound proximity is relatively easy and possible.
5.4 Experimental
5.4.1

Materials
UOx lyophilized powder containing 15∼30 U mg−1 and XO lyophilized powder

containing 7 U mg−1 were purchased from Sigma Aldrich, for UA and Xanthine oxidation
respectively. UA, Xanthine, sodium hydroxide, H2O2, sodium phosphate monobasic
(NaH2PO4) and sodium phosphate dibasic (Na2HPO4) were used of analytical grade. All
aqueous solutions were prepared using deionized (DI) water. Phosphate buffer solution
(PBS) (pH 7.8) (20mM) was used as the electrolyte solution, prepared using NaH2PO4 and
Na2HPO4 salts. Colorimetric UA and Xanthine assay kits were purchased from
ThermoFisher Sc. and Sigma Aldrich respectively and utilized to analyze clinical samples.
PVA-SbQ purchased from Polysciences, Inc., was used to entrap UOx on SPCE purchased
from CH Instruments, Inc., United States and the wound dressing. The flexible electrodes
on wound dressing were screen printed using a 305-mesh screen using conductive graphite
and Ag/AgCl pastes (Gwent Group, UK) on adhesive vinyl (Silhouette America, USA).
The sensor was interfaced with LMP91000 miniaturized potentiostat having an
analog front end (AFE), an ultra-low-power microcontroller (CC2650) integrated with a
bluetooth module and LP2591 power management system from Texas Instruments (TI). A
MCP72831charge controller, 12-bit digital-to-analog converter (DAC) with integrated
electrically erasable programmable read-only memory (EEPROM) and a I2C compatible
serial interface from Microchip formed part of the electronic circuit.
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5.4.2

Apparatus and Methods
A handheld BD-20AC Laboratory Corona Treater was utilized to treat the sensor

surface for improved substrate functionalization. A schematic of the experimental setup is
shown in Fig 5.1b. A goniometer was utilized to record contact angle measurements from
the plasma treated sensor surface using sessile drop technique. This offered an improved
understanding of sensor surface hydrophilicity. Standard electrochemical characterizations
were carried out in a classical three-electrode system consisting of SPCE, external
Ag/AgCl as reference electrode and Pt counter electrode. Testing of the three electrode
system was carried out in an electrochemical cell setup with 3ml electrolyte solution for
both classical and flexible electrodes. Cyclic voltammetry (CV) and differential pulse
voltammetry (DPV) using the analytical system model CHI-230B potentiostat from CH
Instruments, Inc. were conducted to evaluate the sensor performance. The ThermoFisher
Sc. microplate absorbance reader was used to conduct assay experiments.
5.4.3

Sweat sample collection protocol

Before sample collection, a questionnaire was given to the subjects (Figure 5.3) to
identify any health concern.
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Figure 5.3 Survey form handed out to the volunteers from whom human sweat
samples were collected [236]
Four samples were collected from subject volunteers between the age group of 25 to 35.
The subjects identified themselves as African American, Hispanic or Asian. These samples
were collected as shown in Figure 5.4 under institutional review board (IRB) regulations.
Human sweat samples were collected from different healthy deidentified subjects
after a run on a treadmill at a gym for 15 minutes. The 15 min duration was chosen because
most of the subjects started sweating after 10 min.

Figure 5.4 Steps involved in sweat sample collection [236]
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5.4.4

Analyte extraction from wound dressing
Multiple de-identified and discarded wound dressing samples were collected for

UA and Xanthine extraction from patients inflicted with venous leg ulcers at the wound
clinic in University of Miami. Two dressings, each about 10 cm x 10 cm in dimension,
were collected from the subject’s injured leg, placed at two different areas of his skin, at
the time of dressing change. The first dressing was collected from one placed over the
injured gash, while the second from one placed on a healthy region of skin, across from the
one over the wound. Each of these wound dressings were carefully cut to 5 cm x 5 cm, as
shown in Figure 5.5, to extract the biofluid that diffused through the dressings. Different

Figure 5.5 De-identified wound dressings from 5 patients, subjects 1-5 respectively are
shown by green dashed lines (---); red dashed lines (---) represent the extraction area of
wound exudate; blue dashed lines (---) represent the extraction area of biofluid from
perilesional skin and pink dashed lines (---) represent healthy skin extracted area [244]
sections of each dressing as denoted in Figure 5.5, represent the extraction regions of
biofluid from around wound proximity versus further away from it. Each of these samples
were immersed in 5 ml NaOH solution prepared in DI water (0.1 M, pH 12) and incubated
at 370C for forty-five minutes. They were then ultra-sonicated in a homogenizer for 60 s at
20 Hz and centrifuged for 5 minutes to separate the debris and extract the samples from the
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dressings. The extracted solutions of wound exudate and those from perilesional and
healthy skin were tested on the biosensor. Assays for correlating concentrations of UA and
Xanthine in different samples were conducted using standard colorimetric assay protocol
at 570 nm.
5.4.5

Electrode fabrication on wearable construct
Fabrication of electrodes on wound dressing was achieved through screen printing

using conductive graphite paste on adhesive vinyl sheet with a 9 × 14 mesh screen. This
graphite coated adhesive substrate was dried in nitrogen for 4 hours. Electrode design was

Figure 5.6 (a) Steps involved in IOT electrode preparation, (b) Screen printing using
conductive graphite paste, (c) Precise cutting of electrode design, (d) Integration of
flexible electrode on dressing, (e) Flexible electrode on wound dressing [211]
created on Silhouette Studio for precise cutting of the electrodes. This was then transferred
onto flexible wound dressing. Conductive Ag/AgCl paste was coated to create the reference
electrode. The fabricated flexible electrode system on the wound dressing comprised of
carbon working and counter electrodes and an Ag/AgCl reference electrode. On the
working electrode, the enzyme was entrapped using PVA-SbQ as mentioned previously in
classical SPCE. These fabrication steps are schematically represented in Figure 5.6.
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5.5 Effect of Corona Plasma on sensing performance
The effect of Corona Plasma was investigated on the hydrophilicity of the sensor
surface. As portrayed in Figure 5.7, a non-plasma treated electrode showed higher
hydrophobicity with a contact angle of 118.30. The presence of MWCNT/AuNP
nanocomposite on the electrode reduced the contact angle to 115.10. This was further seen
to lower on plasma treatment to 64.80. Incorporation of enzyme to the nanocomposite
(a)

(b)

Figure 5.7 Contact angle measurements recorded from (a) Non-plasma treated and (b)
Plasma treated electrodes
sensor surface showed a further decrease in contact angle to 400. Hydrophilicity of the
surface was thus seen to gradually increase with plasma treatment to the nanocomposite
functionalized enzymatic sensor. This was determined from notable reduction in contact
angle by 78.30 as observed from Figure 5.7.
Effect of corona plasma was thereafter assessed on sensor performance using
electrochemical measurements. Increased hydrophilicity of the sensor surface contributed
to notably higher signal as illustrated from the CV plot depicted in Figure 5.8a. While a
non-plasma treated electrode provided a current of about 0.2 µA, gradual increase in
current was recorded from the plasma treated sensor surfaces. With a non-enzymatic sensor
also providing higher signal on plasma treatment, further higher signal was recorded from
the nanocomposite functionalized enzymatic sensor after being treated. An increase in
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current by about 5-fold was recorded from the nanomaterial based enzymatic sensor
surface as observed from Figure 5.8a.
This sensor was evaluated with different increasing concentrations of UA within a
broad physiological range between 6 nM and 0.4 mM. Linear increase in response was
obtained at an Epa of about 0.3 V as seen from Figure 5.8b. With a low detection limit of
6 nM, the sensor offered a sensitivity of 12 nA µM-1 cm-2 with a correlation of 0.6.
0.8
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Figure 5.8 Plot depicting (a) CV response recorded from plasma treated and non-plasma
treated electrodes in presence of UA, (b) Increase in response to different increasing
concentrations of UA, inset: linear regression plot to increasing UA between 6 nM and
0.4 mM
5.6 Effect of sample volume on sensing performance
Low sample production rates create insufficient liquid channels between the electrodes
in a three-electrode system. Sufficient volume of analyte is thus necessary to facilitate
charge and ion transport. The effects of different increasing sample volumes (0.5 to 50 µL)
were tested using PDMS as a biocompatible substrate[227] for holding small volumes.
(inset: Figure 5.9b). To enable uniform distribution of the sample on the electrode
assembly, a sandwich setup was implemented. The setup includes a layer of PDMS
containing the desired volume of sample, a wound dressing and then the transducer. For
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Figure 5.9 Effect of low sample volume on (a) Epa and (b) Ipa of the biosensor, where
48μM uric acid was measured. The dotted lines in both graphs represent the upper and
lower limits. The plots in the (a) and (b) insets are normal distribution curves
representing potential and current, respectively. The inset schematic in (b) is the
experimental setup [211]
small volume measures, the potential (Epa) falls in the range between 0.2 V and 0.13 V
(Figure 5.9a). Normal distribution of this data provides σ = 0.3 mV, which demonstrates
that low volumes do not affect the Epa of UA. Figure 5.9b shows that Ipa falls in the range
between 0.25 to 0.7 µA with a normal distribution, where σ = 0.4 µA. Measurements have
indicated that this UA biosensor is sensitive enough to detect samples with volumes as low
as 0.5 µL (Figure 5.9). These studies accounted for low volumes present under the wound
dressing in wound proximity of skin for real-time analysis. The measurements made have
also examined for volumes that can spread evenly across the surface of the working
electrode; which is enough to allow conduction of ions between the electrodes and to
amplify signal effectively.
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5.7 Clinical sample evaluation
5.7.1

Measurement of UA in sweat samples
The biosensor was assessed by measuring UA levels present in human sweat

obtained from de-identified samples collected for the study as discussed (Table 5.1- RS1
to RS4). These samples were measured by standard addition method in both UA assay and
biosensor. A correlation between the assay and sensor measurements is drawn in Table 5.1.
It can be seen from Table 5.1, that the UOx biosensor provided a varying recovery between
86.52% and 118.11% and an average RSD of 1.38%. This shows the viability of noninvasive UA detection from human sweat samples.
Sample No.

Assay (µM)

Biosensor (µM)

Recovery (%)

RSD (%)

RS1

9.15

9.75

106.46

1.59

RS2

29.46

34.80

118.11

2.19

RS3

53.03

45.88

86.52

1.31

RS4

64.30

63.95

99.46

0.44

RS1, RS2, RS3 and RS4 represent the different sweat samples
Table 5.1 Colorimetric UA assay vs. electrochemical detection of UA in human sweat
samples using an enzymatic biosensor [236]
5.7.2

Measurement of UA in extracted wound exudate
As discussed in previous sections, healing progress can be monitored from

correlations of UA concentrations in wound exudate. Extracted wound fluid from four
different samples were analyzed using standard UA assay protocols to determine UA
concentrations. The concentration values of the samples are given in Table 5.2, in the added
column. To determine the performance of UOx biosensor in detection, electrochemical
studies were performed to correlate these results with those obtained against standard
colorimetric assay protocol. Different extracted wound fluid samples were tested against a
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linear calibration curve obtained from the standard assay concentrations. The
concentrations values of UA obtained from the extracted samples of wound exudate are
given in Table 5.2 – WF1 to WF4. Analysis from four de-identified patients with wounds
of varying severity, provided us varying recovery of 85–150 % and RSD of about (+/-)
5%.
Sample No.

Assay (µM)

Biosensor (µM)

Recovery (%)

RSD (%)

WF1

76.64

65.21

85.09

4.64

WF2

96.40

85.12

88.29

0.46

WF3

106.40

115.83

108.86

3.91

WF4

34.02

50.61

148.75

10.37

WF1, WF2, WF3 and WF4 represent wound sample extracts from discarded dressings
Table 5.2 Colorimetric UA assay vs. electrochemical detection of UA in extracted
wound fluid of de-identified patients using an enzymatic biosensor [236]

Wound and treatment variations for each patient may vary owing to different levels
of electrolytes and proteins. At any given time, debridement oozing through dressings in
multiple patients may have varying levels of components (electrolytes, lactate, glucose,
and proteins).[159, 199-202, 223, 227-228] Some deviation in response can thus be
ascribed to these differences in wound fluid or sweat composition. For both sweat and
wound extracts, each sample was assessed thrice. The mean of these values have been
provided in Table 5.1 and Table 5.2. The intrinsic characteristics of the CV response
obtained from a sweat and a wound sample extract have been shown in comparison with
buffer (absence of sample) in Figure 5.10. This portrays that higher current is obtained
from a sample extract of wound exudate, therefore suggesting the presence of elevated UA
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concentration in purulent wound fluid as compared to sweat, which contains relatively
lower concentrations of the analyte.
This study establishes the detection of UA from human wound exudate and sweat,
which have not been achieved before. Measurable results obtained from bio-fluids of sweat
and wound pave the potential for electrochemical detection of UA in wound theranostics.

Figure 5.10 Sample plot depicting CV response of the UOx electrode to 1 of the sweat
and wound samples, measured at 20 mV s-1. This data shows wound has higher
concentration of uric acid than sweat as reported [236]
Such a method may potentially facilitate non-invasive biomarker detection from sweat
around a wound, thus preventing occlusion effects from other contaminants in concentrated
wound fluid when embedding the sensor directly on the wound.
5.7.3

Effect of sweat lipid emulsification on sensor signal
Measuring UA form sweat will be influenced by the composition of sweat

metabolites. Secreted from eccrine glands of the skin, sweat helps regulate body
temperature. It is mainly composed of water with dissolved minerals, proteins, and
ions.[229] At any given time, sweat secreted by different people may have varying levels
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of these components. This kind of difference in content could trigger changes in biosensor
measurements.
The biosensor was tested to detect UA in sweat using standard addition method with
samples prepared by spiking known concentrations of UA and testing them against its
linear calibration curve. Two different sources were selected for this study, one clearer than
the other. Increased turbidity in sweat could result from emulsification of lipid/fat
molecules in certain cases.[230] Such variations affect the electrochemical signal. Results
showed that the clearer sample provided a positive recovery while the turbid sample
provided a negative one. This negative value can be attributed to fat molecules blocking

Figure 5.11 Plot representing the effect of fat emulsification in sweat on the biosensor
recovery data obtained through DPV technique. S1, S2 and S3 represent 30.3, 33.9 and
37.5µM uric acid respectively. The top and bottom vial images are the clear and fat
emulsified sweat samples
the electrode surface. Emulsification of lipid molecules could thus be considered as a cause
of change in recovery. These results denoting recovery of UA from the sweat samples are
plotted as seen in Figure 5.11.
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5.7.4

Clinical sample evaluation for Xanthine
Venous leg ulcers and sickle cell disease leg ulcers of de-identified patients within

a week of therapy were analyzed (Figure 5.12). Therapy for such wounds is primarily
compression and pressure oriented, to increase the venous return and reduce venous
hypertension to allay the pressure damage caused in valves of leg veins.[231-232] Analysis
from these dressings showed, that the wound exudate from larger wounds (14 cm2) had
3.25 µM Xanthine compared to 2.77 and 1.85 µM for wounds with an area of 5 cm2 and 1
cm2, respectively. Such a relationship suggests that a correlation may be drawn between
wound severity and Xanthine concentrations;[233] where wounds with a larger area
contain higher concentrations of Xanthine than smaller wounds. A correlation can be drawn
between severe wounds depicting higher analyte concentrations than healing wounds, with
large wounds typically taking longer to heal.[234-235] However, larger number of sample
studies are necessary to validate these correlations.

Figure 5.12 De-identified wound images of patients diagnosed with venous leg ulcers
(a, b) and sickle cell disease leg ulcer (c) [244]
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To assess the ability of Xanthine detection from wound vicinity non-invasively,
extracted biofluids from perilesional and healthy skin were measured for the presence of
Xanthine, along with exudate extracted from wound dressings of five different patients.
The biosensor was evaluated against standard colorimetric assay protocols for Xanthine to
analyze the extracted bio-fluids and determine the concentrations of Xanthine. Results
obtained from this study have been depicted in Table 5.3 and Figure 5.13.

Sample Assay
(µM)
S1
1.39
S2
1.36
S3
1.33
S4
1.33
S5
2.59

Healthy skin
Biosensor
(µM)
1.72
1.34
1.15
2.48
2.00

Recovery
(%)
123.94
98.47
86.22
186.41
77.29

Injured skin

Perilesional skin
RSD
0.60
0.52
0.41
0.41
0.27

Assay
(µM)
1.45
1.51
1.36
2.97
2.91

Biosensor Recovery
RSD
(µM)
(%)
1.91
132.18 0.69
2.12
140.48 0.94
1.54
112.89
0.40
0.18
2.74
92.20
2.23
76.69
0.19

Assay
(µM)
1.46
5.63
7.48
3.35
4.50

Biosensor
(µM)
3.25
2.77
1.85
2.83
6.48

Recovery
(%)
222.32
49.22
24.74
84.41
143.94

RSD
0.37
0.10
0.11
0.25
0.12

S1, S2, S3, S4 and S5 represent the samples from de-identified patients
Table 5.3 Detection of xanthine in extracted wound exudate, biofluid from perilesional
and healthy skin of de-identified patients using the biosensor [244]

Figure 5.13 Concentrations of xanthine concentrations from extracts of biofluids
sampled from (a) healthy skin, (b) perilesional skin and (c) wound exudate of five deidentified patients using the biosensor [244]
Analyte concentrations were observed to be higher from extracted wound exudate
than from further away from the injury site. Biofluids from healthy skin showed
comparatively lower concentrations. This indicates that concentrations of xanthine are
higher in wound proximity and are reduced when further away from the lesion site. A
correlation between the assay and sensor measurements as portrayed in Table 5.3, shows
that the biosensor readings have high deviations for wound exudate measurements as
compared to measurements from perilesional and healthy skin. These deviations are
reflected in their recovery values as seen in the same table, where wound exudate has about
122% deviation, while extracts from perilesional and healthy skin have lower deviations
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of approximately 40.48% and 86.41%, respectively. This deviation in response can be
accredited to differences from the presence of various electrolytes and proteins in the
biofluid matrices.
This study provided an understanding of the concentration gradient of the bioanalyte in wound proximity. On the occurrence of a wound, fluid oozes in and around the
punctured tissue by diffusing through glands and surrounding tissue through the internal,
lower dermal layers of skin due to changes in osmotic gradients of the metabolites.[236]
Therefore, the area around the wound also has a rise in analyte concentrations. It can be
seen from this study that measuring Xanthine from biofluids in and around the injury of a
person is possible and not at all cumbersome. This shall also allow reduction of occlusion
from embedding the sensor directly on the wound.
5.7.5

Effect of biofluid occlusion on sensor surface
The effect of biofluid occlusion on the active surface of the biosensor was studied

through electrochemical analysis. It showed the rate of degrade in response to sequential
deposition of extracts of wound exudate and biofluids from around the wound. The sensor
showed a gradual decrease in response to extracts from perilesional and healthy skin with
the same volume of analyte. As illustrated in Figure 5.14, the rate of decrease in response
to wound exudate was 20 % more than when subjected to extracts from around and away
from the wound. This higher rate of decrease can be attributed to the occlusion of solid
proteins, proteases, cytokines and neutrophils present in concentrated wound exudate, on
the active area of the electrode. Such accumulation tends to block the electrode surface,
limiting the diffusion of analyte to the transducer and promoting electrode fouling.
Measurements recorded over different sequential deposition of analyte have shown that the
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response of the enzymatic electrode was reduced by only 10% in the presence of biofluid
from healthy skin before attaining stability. It can thus be said that the enzymatic biosensor
could potentially be utilized for wound healing therapy through assessment of Xanthine
levels from biofluids in injured vicinity.

Figure 5.14 Plot depicting percentage change in current response of the biosensor as a
function of volume of extracted biofluids from (a) healthy skin, (b) perilesional skin
and (c) wound exudate [244]
5.8 Electrochemical sensing performance on wearable platform
Sensing operation from wearable platform - The enzymatic sensor designed on cotton
gauze was interfaced with an analog front end (AFE), LMP91000 on a flexible platform.
The customized printed circuit board (PCB) was manufactured on flexible Kapton tape
with a two-layer board ∼ 800 microns thick (Figure 5.15a). It was designed to

accommodate the low-cost potentiostat (LMP91000) with a low power data processing
microcontroller, CC2650 integrated with a bluetooth module for wireless data
transmission.
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A schematic of the potentiostat is given in Figure 5.15b. The arrangement of the
circuit is that of a non-inverting operational amplifier. LMP91000 was configured via the
microcontroller, CC2650 to perform three electrode amperometry according to the
schematic in Figure 5.15b. Microcontroller, CC2650 was used as an integrated wireless
microcontroller with bluetooth low energy (BLE) capabilities to provide wireless
communication and peripheral controls remotely at ultra-low power cost-effectively with
its 2.4 GHz transceiver. It was connected to the LMP via the I2C interface, as in Figure
5.15c.

Figure 5.15 (a) Flexible electronics; (b) Schematic of the potentiostat and connections;
(c) Circuit design of components embedded on the PCB interfaced with the flexible
wound sensor [211]
As depicted in Figure 5.15b, amplifier A1 is the control amplifier that implements
the potentiostat circuit. The variable bias block provides a constant potential across the
working and reference terminals of A1. The voltage supplied by the source was closely
followed by the voltage between the reference and working electrodes. All three electrodes
on the dressing were connected to corresponding pins of the AFE, linked to the
microcontroller, CC2650 as shown in Figure 5.15c. Electronic components including the
microcontroller, AFE, power management systems with BLE Antenna, I/O device chip,
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MPU, memory chip and associated circuitry were mounted on the top layer as shown in
Figure 5.15c.
The transition from minimal current flow to voltage was made available by the
trans-impedance amplifier (TIA) whose forward voltage gain depends on feedback resistor
Rtia, connected to the feedback path of the TIA. This converts the current flowing between
the counter and working electrodes to a proportional voltage, connected to Vout. Vout from
the LMP91000 was routed to the microcontroller general purpose input/output, where it
was conditioned by an internal analog-to-digital converter for interpretation. The internal
feedback resistor was optimized for optimal amplifier gain through Rtia = 120 kΩ, which
offered large enough gain to allow for voltage fluctuations owing to changes in analyte
concentrations. The reference voltage (VREF) to the AFE sensing device was externally
provided by the digital to analog converter. The developed wearable platform operated on
a 3.7 VDC lithium-ion (Li-ion) battery capable of providing up to 350 mAh. The Li-ion
battery used can be recharged on the wearable platform through a micro-USB device
connected directly onto a charging circuit allowing simultaneous system operation and
charging. Battery voltage was regulated to provide a constant 0.3 VDC source to the system
in through a battery voltage range of 3 VDC ≤ VDC ≤ 3.7 VDC. When bluetooth capabilities
were enabled by the user, the current consumption of the system increased from 2 to ∼ 40

mA. This current generated by the potentiostat from the working electrode, corresponds to
the concentration of the analyte. [211]
Power consumption of the device depends not only on the amperometric operation
of the potentiostat, but also on the BLE transmission and communication; along with the
run time current drawn from the central processing unit (CPU). Since most of these
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operations do not simultaneously run except in emergency mode, the modules running
them could be pushed to a low power state, reducing consumption. For precise calibration,
the computational power being demanding on all devices, processing of information can
be performed on the cloud on data upload. This saves battery power and comparatively
limits computational power over the device and low energy Bluetooth. While the CPU runs
for a shorter duration during BLE transmission and conversion of the analog output from
the potentiostat, the remaining time can be used for other peripheral operations consuming
an average power of ∼56 μW over a 3.7 V and 350 mAh battery, providing a system
operational lifetime of multiple days. [211]

Response from wearable construct - Response from a classical electrode setup was
compared to that obtained from the sensor designed on gauze. With a mean response of
about 4.27 μA, a standard deviation of 0.6 μA was observed as depicted in Figure. 5.16a.
A slight shift in potential was also noticed with a standard deviation of 0.01 V as seen in
Figure. 5.16b. This information was then sent wirelessly via bluetooth to the receiver which
possesses abilities to send the data to the cloud. Information processed and sent from the

Figure 5.16 Bland-Altman plots representing variation in (a) current and (b) potential
from studies using classical setup and IoT platform in presence of 100 μM UA,
measured at 20 mV s−1. E1 and E2 represent the classical SPCE and biosensor on fabric
respectively [211]
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bluetooth module to the receiving device was encrypted to avoid data compromise and
enable secure transmission.[237]
Such a system could therefore enable patient-physician remote monitoring.[238]
Analytical tools could be built on the cloud for data analysis of corresponding wound
biomarker concentrations to monitor wound severity and healing progress.
5.9 Conclusion
Enzymatic potentiometric biosensors were designed on cotton gauze for wearable
monitoring of wound biomarkers, UA and Xanthine. The detection of UA and Xanthine
from extracted biofluids of wound exudate and sweat was established for the first time
through this study. Detection from bio-fluid matrices around an injured site was evaluated,
with portrayed higher concentrations in wound proximity than further away. Possibility of
non-invasive detection from wound milieu was explored to show the feasibility of
biomarker detection from wound proximity. Results have shown a correlation between
wound dimensions and analyte concentrations. This study paves the potential for detection
of purine metabolites from biofluids in and around the wound, on a wearable, healing
platform. This shall enable non-invasive assessment of lesion severity, providing
quantitative insights on healing progress.
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CHAPTER 6
SUMMARY AND FUTURE DIRECTION
6.1 Summary
Point-of-care techniques, entailing the detection of specific biomolecules can enable
quantitative monitoring of a wound’s healing progress. As an attempt to transform woundcare with continuous monitoring of healing and effective wound management, this
dissertation discusses the feasibility of a biosensing system on a wearable, healing
platform. A bio-sensing system that can electrochemically detect analytes like UA and
Xanthine can potentially evaluate the healing progress of a wound, bearing correlations
with wound severity.
Methods to stabilize the sensing performance have been implemented through specific
sensor surface modifications and robust enzyme immobilization protocols in sensor design.
The use of nanomaterial in sensor design was assessed using a nanocomposite of
MWCNT/AuNP. Enhanced sensing performance was noted from increased active surface
area and binding sites offered by the conductive nano-composite, which enabled higher
loading of enzyme and firm immobilization. The use of Corona Plasma was noted to
improve sensing response with increased hydrophilicity, enabling greater surface
functionalization. Stability and shelf life of the biosensor over multiple days was assessed
under relevant physiological variations of temperature and pH using electrochemical
techniques. The validation of sensor performance in extracts from bio-fluid matrices
associated with an injury site was performed using electrochemical and colorimetric
approaches. Viability of detection of UA and Xanthine from these extracts of relevant
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biofluids was conducted to observe correlations between wound severity and the
concentrations of UA and Xanthine.
6.2 Prospects
Existing wound care being expensive can cause stress and inconvenience to patients.
The importance of patient compliance by health professionals is crucial and can make a
huge difference between optimal wound healing and unwanted health issues. Wearable
biosensing for wound management offers promise in cost reduction and convenience for
the patient through smart technology, minimizing exacerbation. [211]

Figure 6.1 Schematic representing the convergence of smart wound care management
and IOT [211]
Of late, the rise of digital medicine is revolutionizing traditional laboratory-based
treatment protocols with access to real-time patient data and remote patient monitoring in
personal health management.[239] The advent of the medical IoT, will enable real-time
continuous tracking of healing through miniaturized, remote sensing. This evolution
presents enormous potential for convenient, personalized wound care, which can assist in
taking medical decisions through the healing stages as and when necessary. In this age of
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healthcare, a network of devices and appliances embedded with electronics, software and
sensors, connected to exchange data, can create breakthroughs in personalized medicine.
A biosensor to monitor wound biomarkers shows the possibility of continuous
monitoring of lesion healing in physiologically relevant conditions. Correlation of analyte
levels with pH and temperature in an injured environment, can enable calibration of
response through sensor fusion. Figure 6.1 depicts the convergence of wound management
with medical IoT. Advancing toward personalized wellness evaluation, the sensor
complements comprehensive wound management on a flexible, wound-care platform. This
sensing system as shown in Figure 6.1, will allow remote patient-physician
engagements[240], enable setting up of appointments and validation of treatment based on
data acquired at a personal scale. Such tools will provide powerful wound care solutions
for effective therapy to continuously monitor recovery progress and detect chronicity
through rapid analyses from wound milieu.
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